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ABSTRACT 
In the past few decades, a revolution in our understanding of brain function has 
occurred based on demonstrations that astrocytes play critical roles in synaptic 
physiology. These findings led to the concept of the “tripartite synapse,” which redefines 
the synapse to be comprised of not only the pre- and postsynaptic neuronal elements, but 
also the astrocyte processes that interact with them. Likewise, temporal lobe epilepsy 
(TLE) is a seizure disorder that affects the structure and function of networks of both 
neurons and astrocytes. One of the hallmark findings in TLE is the profound change in 
astrocyte structure and gene expression, a process called astrogliosis, throughout the 
brain regions involved in seizure generation. Using a well-established rat model of TLE, 
our lab recently demonstrated that astrocytes begin to express kainate receptor subunits 
during the development of TLE, and this increased expression persists throughout chronic 
epilepsy, suggesting that this pathway may play a role in the development of 
hyperexcitable circuits. However, the functional consequences of changes in reactive 
astrocytes and their impact on tripartite synapse function are not known. 
To facilitate imaging experiments at the tripartite synapse, I developed a novel 
genetic tool that uses a fluorescent reporter system to label astrocytes with tdTomato and 
neurons with Cerulean. This plasmid also includes the genetically encoded calcium-
indicating protein, Lck-GCaMP6f, enabling the monitoring of calcium transients in the 
fine processes of all transfected cells. I expressed this novel tool in the rat brain with in 
iv 
utero electroporation and characterized expression throughout development using 
immunohistochemistry for markers of astrocytes and neurons. I demonstrated the utility 
of this tool to investigate functional subcellular Ca2+ signals in both astrocytes and 
neurons. This tool was used in experiments that showed that Ca2+ signaling is altered 
during the development of temporal lobe epilepsy in the rat kainic acid-induced model of 
status epilepticus. Spontaneous Ca2+ events in the processes of reactive astrocytes 
exhibited longer interevent intervals and longer duration of events compared to astrocytes 
from healthy tissue. I also found that increased protein expression of kainate receptors 
translated to functional expression of kainate receptors on a subset of reactive astrocytes 
following kainic acid-induced SE, suggesting a pathway that may be involved in 
pathological neuron-glial signaling contributing to the development of epilepsy. 
Taken together, these results indicate that alterations in Ca2+ signaling in 
astrocytes during the development of TLE may have important consequences on function 
at the tripartite synapse. This dissertation lays the groundwork for future studies in the 
tripartite synapse and points to a novel pathway that may be involved in pathological 
neuron-astrocyte signaling that contributes to hyperexcitability during epileptogenesis.
This dissertation is dedicated to my mom, Geri Gibbons, for her unconditional love and 
support. 
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CHAPTER 1 
CONTRIBUTIONS OF ASTROCYTES TO EPILEPTOGENESIS FOLLOWING 
STATUS EPILEPTICUS: OPPORTUNITY FOR PREVENTIVE THERAPY? 
The Journal of Neurochemistry International (2013). Contributions of astrocytes to 
epileptogenesis following status epilepticus: opportunity for preventive therapy? Gibbons 
MB, Smeal RM, Takahashi DK, Vargas JR, Wilcox KS. (2013).” © Owned by the 
authors, published by Journal of Neurochemistry International. Reprinted with 




Status epilepticus (SE) is a life threatening condition that often precedes the 
development of epilepsy. Traditional treatments for epilepsy have been focused on 
targeting neuronal mechanisms contributing to hyperexcitability, however, approximately 
30% of patients with epilepsy do not respond to existing neurocentric pharmacotherapies. 
A growing body of evidence has demonstrated that profound changes in the morphology 
and function of astrocytes accompany SE and persist in epilepsy. Astrocytes are 
increasingly recognized for their diverse roles in modulating neuronal activity, and 
understanding the changes in astrocytes following SE could provide important clues 
about the mechanisms underlying seizure generation and termination. By understanding 
the contributions of astrocytes to the network changes underlying epileptogenesis and the 
development of epilepsy, we will gain a greater appreciation of the contributions of 
astrocytes to dynamic circuit changes, which will enable us to develop more successful 
therapies to prevent and treat epilepsy. This review summarizes changes in astrocytes 
following SE in animal models of SE and human temporal lobe epilepsy and addresses 
the functional consequences of those changes that may provide clues to the process of 
epileptogenesis. 
 
Status Epilepticus Can Result in Temporal Lobe Epilepsy 
Status epilepticus (SE) is a medical emergency with a poor prognosis. It is defined 
as continuous seizure activity lasting greater than 10 minutes or two or more sequential 
seizures without full recovery between seizures (Lowenstein et al., 1999). While the risk 
of death following SE has declined somewhat in the industrialized world, older patients 
experiencing prolonged SE are still at high risk of death. Furthermore, patients who 
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survive a prolonged bout of SE often experience cognitive decline and develop epilepsy 
(Engel, 1996). Patients with temporal lobe epilepsy (TLE) often first present with SE. 
TLE is a common seizure disorder characterized by complex partial seizures that can 
secondarily generalize and are often pharmacoresistant to currently available anti-seizure 
drugs (ASDs). Because SE can result in difficult to treat forms of epilepsy such as TLE, it 
is the focus of much research. 
Administration of chemoconvulsant agents and electrical stimulation have been 
used in rodents to induce SE that is then followed by the progressive development of 
epilepsy. Two of the most well studied rodent models of SE are the systemic kainic acid 
(KA) and pilocarpine (PILO) models. Following injection of either of these two agents, 
animals begin a bout of SE that can last hours (Curia et al., 2008; Lehmkuhle et al., 
2009). While mortality is lower for the KA model, survival can be enhanced in the PILO 
model by treatment with a variety of anticonvulsant agents after about an hour of SE. 
After a latent period of several days to weeks following SE, animals develop recurrent 
seizures that are limbic in origin. Animals treated with a repeated low-dose paradigm of 
KA have been found to develop spontaneous convulsant seizures on average 18 days 
following SE (Williams et al., 2009), while animals treated with pilocarpine begin to 
exhibit spontaneous seizures earlier, with some reported seizures occurring within five 
days following SE (Raol et al., 2006). Likewise, electrical stimulation of the perforant 
pathway can induce sustained SE that is followed by the development of recurrent 
seizures. Depending on the stimulus paradigms used to evoke SE in these models, 
spontaneous seizures can begin within days (Bumanglag and Sloviter, 2008; Norwood et 
al., 2010). In all of these models, considerable neuronal cell death is observed throughout 
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the brain and astrocytes begin to exhibit signs of reactive gliosis soon after evoking SE 
(do Nascimento et al., 2012; Glushakova et al., 2012; Lauritzen et al., 2012a). Animal 
models of SE-induced epilepsy provide an unparalleled opportunity to unravel the 
complex changes that occur in the CNS following SE and during the process of 
epileptogenesis. In particular, they help identify disease-modifying therapies that can 
prevent the development of epilepsy following SE or stop the progression of seizure 
activity once epilepsy is established. While much is known about the complex changes 
that occur in neurons following SE in these animal models, researchers are now 
investigating the changes that occur in astrocytes following SE. Astrocytes post SE may 
acquire functional changes that contribute to, or even prevent, network excitability. By 
understanding these functional changes in astrocytes, it may be possible to identify novel 
therapeutic targets or strategies for the prevention of epilepsy. In this review, we will 
focus our attention on recent findings of the effect of SE or related CNS insults on 
astrocyte function in limbic and cortical regions known to be associated with the 
initiation of seizure activity and the development of epilepsy. 
 
Astrocytes Become Reactive Following SE and This Persists 
in Epilepsy 
Since their discovery over 100 years ago, glial cells have traditionally been 
considered only as passive support cells of the nervous system (for reviews on the history 
of glial research, see Garcia-Marin et al., 2007; Somjen, 1988; Verkhratsky, 2006). 
However, recent application of cellular imaging, physiology, and genetics to astrocytes 
has shown that they are active participants at the neuronal synapse; their diverse roles are 
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entwined with the function of neurons. The structural and functional relationship between 
astrocytes and the neuronal synapse has led to the use of the term “tripartite synapse” to 
reflect the important contribution of astrocytes in influencing synaptic transmission 
(Halassa et al., 2007). The processes of astrocytes are in close proximity to neuronal 
membranes and express a host of receptors, transporters, and ion channels that enable 
astrocytes to “listen” to the chemical conversation at the synapse. In return, they are able 
to “respond” and modify the tone of synaptic transmission by regulating the availability 
of neurotransmitters and ions in the synaptic cleft, such as glutamate and potassium. 
As a consequence of SE and subsequent inflammation, astrocytes change their 
morphology and protein expression in a process termed reactive astrogliosis. A number 
of molecules and signaling pathways are known to trigger reactive astrogliosis (for a 
comprehensive review, see (Sofroniew, 2009)) and many of those receptors/pathways are 
activated as a consequence of SE. Molecules released from dying neurons, such as 
reactive oxygen species, ATP and glutamate, are all known to induce astrogliosis. In 
addition, inflammatory cytokines such as TNF-α and Il1-β are also known triggers and 
these cytokines can be released by microglia and neurons following SE. Interestingly, 
cytokines are also released by reactive astrocytes, which can result in a feed-forward 
system that enhances gliosis (Vezzani et al., 2011). Furthermore, the JAK-STAT pathway 
is known to be elevated as a consequence of SE and this pathway, when stimulated, can 
also contribute to the observed changes in astrocytes (Lund et al., 2008; Sofroniew, 
2009). 
While reactive astrogliosis is one of the most common pathological lesions in 
epilepsy and other brain insults, it continues to be poorly understood. Dramatic changes 
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in the expression of neurotransmitter receptors, voltage gated ion channels, inflammatory 
cytokines, and other proteins, have been identified in astrocytes in both animal models 
and human TLE. However, the time course and the functional significance of such 
diverse changes that accompany astrogliosis is not clear and it is currently unknown to 
what extent “reactive astrocytes” either contribute to, or prevent the ultimate 
development of TLE. Indeed, some components of reactive astrogliosis may be critical 
compensatory mechanisms following injury, resulting in the dampening of excitability, 
while other changes, e.g. decreased expression of aquaporin, may in fact contribute to 
epileptogenesis and/or seizure generation (Lee et al., 2012). Finally, it is possible that 
some alterations in structure and/or function of astrocytes may even be unrelated to 
epileptogenesis. We contend that the study of the role of reactive astrogliosis in 
epileptogenesis is in its infancy and therefore, before disease modifying therapies can be 
identified for the treatment and/or prevention of SE-induced epilepsy, a mechanistic 
understanding of structure and function of reactive astrocytes in the disease process must 
be attained. 
 
Properties of Reactive Gliosis Following SE 
Following SE, reactive astrocytes become hypertrophic, increase expression of 
intermediate filament proteins (for example, GFAP), and develop longer and thicker 
processes (Binder and Steinhauser, 2006) (Figure 1). Although the functional 
consequence of changes in domain organization (see below) and hypertrophied processes 
with increased expression for GFAP are not exactly clear (Fedele et al., 2005; Gouder et 
al., 2004), some of the changes in expression of other proteins could have direct 
  
7 
consequences on the regulatory mechanisms of gene transcription in reactive astrocytes 
(Ridet et al., 1997). The term “reactive astrocyte” is rather ambiguous because reactive 
astrogliosis is not an all-or-none response (Sofroniew, 2009). There can be significant 
diversity within a reactive astrocyte population (Kálmán, 2003; Ridet et al., 
1997). Mild to moderate gliosis, found early on in SE models, typically does not induce 
the proliferation of new astrocytes (Fernaud-Espinosa et al., 1993; Sofroniew, 2009). 
There are, however, some studies that have addressed the proliferative ability of 
astrocytes in the CA fields of the hippocampus following KA-induced SE or lesions 
(Murabe et al., 1982; Niquet et al., 1994). These studies show that while astrocytes can in 
fact proliferate after insult, the proliferation accounts for a very small number of the new 
cells in the area, suggesting that in models of SE, reactive astrocytes are comprised 
mainly of the resident astrocytes present before the insult. 
Two of the hallmarks of reactive astrocytes are the increase in expression of 
intermediate filament proteins (for example, GFAP) in response to injury (Ridet et al., 
1997) and hypertrophy of the main cytoskeletal branches. During this process, however, 
the fine spongiform processes of astrocytes are not immunoreactive for intermediate 
filaments. GFAP immunolabeling, therefore, does not detect changes in the spatial 
domains (i.e., cell volume) of reactive astrocytes in the neuropil. Changes in domain 
organization in reactive astrocytes are important to consider, as they may be indicative of 
astrocytes that are no longer controlling or modulating the same group of synapses and 
these changes could indicate pathological astrocyte-astrocyte or astrocyte-neuron 
relationships. 
Two independent groups investigated whether domain organization is preserved 
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in reactive astrocytes. Wilhelmsson et al. (2006) dye filled astrocytes in the hippocampus 
following disruption of the perforant path from the entorhinal cortex. In this model, 
astrocytes increased the expression of GFAP and were reactive (presumably due to the 
axonal degeneration of the perforant path) but did not change their domain volume and 
did not interdigitate with neighboring astrocytes; thus, reactive astrocytes in this model 
maintained their spatial domains. In contrast, Oberheim et al. (2008) diolistically labeled 
astrocytes in the hippocampus of three mouse models of epilepsy: the ferrous chloride 
model of post traumatic epilepsy, KA-induced SE model, and the SWXL-4 mouse, a 
genetic model of epilepsy. Hypertrophied astrocytes (observed with GFAP) in these 
models of epilepsy had increased domain volumes and almost a complete loss of domain 
organization (observed with diolistic labeling). These changes were observed 1 week post 
injection of ferrous chloride, and 6 months after, during a time of chronic seizure activity. 
Interestingly, in ferrous chloride injected animals whose seizures were reduced with the 
anti-epileptic drug valproate, astrocytes were less hypertrophied, had domain volumes 
similar to controls, and did not lose their domain organization by interdigitating 
extensively with neighboring astrocytes. Therefore, changes in domain organization 
paralleled the severity of seizure activity. 
The results from these studies on the changes in spatial domains of reactive 
astrocytes suggest that a loss of domain organization may be specific to astrocytes in 
epileptic tissue. In support of this notion, Oberheim et al. (2008) noted that reactive 
astrocytes in a mouse model of Alzheimer’s disease did not lose their domain 
organization, even though the astrocytes in this model were reactive (i.e., hypertrophied 
processes and an increase in GFAP expression). The research highlights two salient 
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points. The first point is that reactive astrocytes, as determined by increased 
immunoreactivity to GFAP and hypertrophied processes, may not be homogeneous. 
Astrocytes may respond differently according to the type of cerebral insult, even though 
they may appear identical by immunohistochemistry (i.e., reactive, as revealed by 
GFAP). Indeed, recent genomic analysis of reactive astrocytes revealed a different 
pattern of gene expression depending on the type of insult (Zamanian et al., 2012). The 
CNS insults compared in this study were ischemia and LPS injection. Therefore, while it 
is not clear what patterns of gene expression would be observed following SE, it is 
possible that an entirely different gene expression pattern would be observed. Second, 
reactive astrocytes that have lost their domain organization in epileptic tissue may confer 
unique functional properties that are specific to this neurological disorder. Based on the 
differences in structural changes, therefore, reactive astrocytes in various models of 
neuronal injury may have different functional properties. This is particularly important to 
note because reactive astrocytes are often considered a homogenous population, although 
the data increasingly indicates that the term reactive gliosis encompasses a very wide 
range of features with important functional consequences to studying pathologies. An 
additional point to consider is that the work described above was performed in rodents. 
However, there exists a dramatic heterogeneity of human astrocytes. It is not currently 
known how the individual types of human astrocytes differentially respond to either SE 









Potassium Buffering Is Not Altered Shortly After SE 
Astrocytes play a critical role in maintaining neuronal homeostasis by buffering 
extracellular potassium (K+) through the highly permeable, inwardly rectifying 
potassium channel KIR4.1 (Higashi et al., 2001; Poopalasundaram et al., 2000). Neurons 
extrude K+ with each action potential repolarization (Dichter et al., 1972) and during 
periods of high activity, K+ concentration in the extracellular space can be rapidly 
elevated (Nicholson and Sykova, 1998). Thus, the tight regulation of [K+]o via astrocytic 
uptake is critical for maintaining neuronal homeostasis. Given the importance of KIR 
channels in spatial buffering and the role of potassium in neuronal function, it is no 
surprise that its role has been heavily investigated in epilepsy. For instance, conditional 
knock-out of the KIR 4.1 channel in mice results in behavioral ataxia, seizures, and early 
lethality is observed resulting from deficient K+ uptake in astrocytes (Djukic et al., 
2007). Likewise, in the sclerotic hippocampus of patients with TLE, the KIR channel 
blocker Ba2+ was shown to be ineffective in increasing extracellular potassium levels 
measured by potassium selective microelectrodes in response to stimulus as was 
expected, suggesting dysfunction in KIR channels (Kivi et al., 2000). This finding was 
also observed in some brain slices obtained from epileptic rats that had received 
pilocarpine to induce SE (Gabriel et al., 1998). These results were corroborated using 
patch-clamp electrophysiology in acute hippocampal slices obtained from surgical 
specimens of patients with TLE, which showed reduced inward rectifying potassium 
conductances in reactive astrocytes from this tissue (Hinterkeuser et al., 2000). Together 
these findings support the altered ability of astrocytes to effectively buffer potassium in 
epileptic tissue. However, until recently, changes in KIR and potassium uptake have not 
  
11 
been investigated in reactive astrocytes during the latent period in an animal model of 
SE-induced MTLE. Studies from our laboratory (Takahashi et al. 2010) have 
demonstrated that potassium conductances were not altered in astrocytes during the latent 
period one-two weeks following SE in the KA-treated rat. This finding suggests that soon 
after SE and prior to the development of epilepsy, astrocyte potassium buffering 
capability remains intact. Further investigation is necessary to determine how and if KIR 
function contributes to epileptogenesis. Indeed, therapeutic strategies which result in the 
continued expression and function of specific KIR channels in astrocytes might prove to 
be useful in delaying the onset of epilepsy following SE. 
 
Gap Junctions Between Astrocytes Increase Following SE 
Astrocytes are by far the most extensively gap junction coupled cells in the 
central nervous system and are critical in maintaining homeostatic balance of ions and 
molecules (for reviews, see Kielian, 2008; Nagy and Rash, 2000; Theis et al., 2005). A 
complete gap junction is formed by the direct contact of two opposing hemichannels, or 
connexons, on two different cells. Each connexon consists of a hexameric structure 
consisting of six connexin (Cx) proteins with a hydrophilic pore at its center. This pore 
allows transfer of ions, second messengers, metabolites, and other small molecules 
(Nakase and Naus, 2004), allowing not only electrical coupling between cells but also 
chemical and metabolic coupling. Astrocytes express predominately Cx43 and Cx30 and 
form a metabolically coupled syncytium in CNS tissue (Rash et al., 2001). Our laboratory 
recently showed that the number of coupled astrocytes in brain slices was significantly 
increased in KA-treated rats early in the process of epileptogenesis, and consistent with 
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that observation, CX43 expression was greatly elevated (Takahashi et al., 2010). 
Interestingly, in brain slices obtained from normal rats, epileptiform burst-like activity 
has been shown to enhance coupling between astrocytes in a rapid activity dependent 
manner (Rouach et al., 2008). The extent of coupling in astrocytes is thought to underlie 
spatial buffering and the ability to redistribute potassium and glutamate (Theis et al., 
2005). Gap junction coupling has also been implicated in spreading depression, a 
pathophysiological phenomenon in the CNS characterized by a combined reaction of 
neurons and glia in the form of a propagating wave of neuronal depolarization followed 
by neuronal inactivation. Interestingly, a conditional knock out of the main gap junction 
protein in astrocytes, connexin (Cx) 43 results in an animal with decreased intracellular 
coupling among astrocytes and enhanced velocity in the wave of spreading depression 
(Theis et al., 2003), suggesting that the redistribution of ions and intracellular molecules 
in astrocytes is critical for minimizing spreading depression and hyperexcitability. 
Therefore, in animals experiencing SE, an increase in gap junctionally-coupled astrocytes 
could be viewed as compensatory, with an enhanced capacity for buffering both 
glutamate and potassium. 
The data concerning the expression of Cx43 and Cx30 in other models of chronic 
epilepsy and in human resected tissue are conflicting. In the kindled rat and tetanus toxin-
induced model of epilepsy, no change in mRNA of Cx43 was observed four weeks 
following injury (Elisevich et al., 1997a). Likewise, no change in mRNA or protein 
expression of Cx43 or Cx30 was detected in kindled rats and in the kainate-treated rat 
four weeks following injury (Sohl et al., 2000). However, in human resected tissue from 
patients with intractable epilepsy, Cx43 mRNA and protein are generally shown to be 
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increased (Collignon et al., 2006; Fonseca et al., 2002; Naus et al., 1991) except for 
(Elisevich et al., 1997b). There is evidence of increased gap junction coupling by 
measuring calcium signaling induced by glutamate exposure using fluorescence recovery 
after photo bleaching (FRAP) assays in surgically resected tissue (Lee et al., 1995). These 
findings suggest that gap junction coupling, along with increased Cx43 and Cx30 
expression, might be a common feature in human epilepsy, something not always 
recapitulated in animal models of chronic epilepsy. Some of the discrepancies between 
studies could be due to the dynamic nature of the connexin protein. Connexins have a 
rapid turnover rate of ~1 hour and the antigens that have been used to label Cx43 in the 
past were difficult to detect and were sensitive to fixation (Hossain et al., 1994; Laird et 
al., 1991). 
 
Glutamate Transporter Function Is Enhanced Following SE 
Unlike other neurotransmitters that can be enzymatically degraded after being 
released into the synaptic cleft, glutamate must be actively removed by Na+-dependent 
glutamate transporters. Fast efficient clearance is essential for high signal-to-noise ratios 
in neurotransmission and for the prevention of excitotoxicity (for review see Danbolt, 
2001; Marcaggi and Attwell, 2004; Tzingounis and Wadiche, 2007). The main glutamate 
transporters, GLAST and GLT-1 are predominately expressed in astrocytes (Lehre et al., 
1995), and are responsible for >90% of the total glutamate uptake (Tanaka et al., 1997). 
The alterations that occur to this system, as well as the closely linked processes 
governing glutamate and glutamine cycling during epilepsy are complex and the 
literature is often conflicting in regards to changes in glutamate transporter expression 
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following SE.  
In animal models, as would be expected, knock down of GLT-1 expression in the 
mouse leads to neuronal loss and seizure activity that is caused by the build-up of 
extracellular glutamate (Tanaka et al., 1997). Similarly, eight weeks following 
stereotaxically injected KA into the amygdala of rats, spontaneous motor seizure activity 
was observed and hippocampal tissue homogenates showed reduced expression of GLT-1 
and GLAST (Ueda et al., 2001). In human tissue from patients with TLE, 
immunohistochemistry consistently demonstrates reductions in GLT-1 and GLAST 
expression (Mathern et al., 1999; Proper et al., 2002; Sarac et al., 2009). However, 
similar studies in human tissue using Western Blotting on hippocampal homogenates do 
not show a change in GLT-1 or GLAST expression (Bjornsen et al., 2007; Tessler et al., 
1999). However, the changes in transporter protein expression described above do not 
provide a direct assessment of the changes in transporter dependent glutamate uptake in 
epilepsy. A more quantitative measurement of transporter function, and hence glutamate 
clearance, in epileptic tissue is to directly record synaptically evoked glutamate 
transporter dependent currents in reactive hippocampal astrocytes. 
In a recent study, we recorded from astrocytes in hippocampal brain slices 
obtained from control animals and those that had been subjected to KA-induced SE. We 
demonstrated that there is no effect of SE on the amplitude of glutamate transport 
currents, nor any concomitant change in the expression of GLT-1 expressed in astrocytes 
within 1-2 weeks after SE. However, we did determine that there is a significant decrease 
in the decay kinetics of glutamate transport currents recorded in reactive astrocytes, 
suggesting that following SE, astrocytes have an enhanced capacity to more quickly take 
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up extracellular glutamate (Takahashi et al., 2010). Previous work by other investigators 
demonstrated that the time course of glutamate transport currents is not affected by 
changes in stimulus strength, the probability of release of glutamate, or the diffusion 
kinetics of glutamate. Instead, the rate of decay of the current is likely due to a variety of 
mechanisms, including the number and type of glutamate transporters present at the 
synapse and the extracellular volume (Diamond, 2005; Diamond and Jahr, 2000). 
Therefore, there are several hypotheses that could explain the faster kinetics of the 
glutamate transport currents in reactive astrocytes. For example, it has recently been 
demonstrated that the GLT-1 transporter is rapidly trafficked to activated synapses. 
(Benediktsson et al., 2012). Therefore, it is possible that following the intense neural 
activity that occurs during SE, existing transporters may be trafficked to activated 
synapses. It is also known that several astrocyte signaling pathways can regulate 
glutamate transporter trafficking (Robinson, 2002) and while we did not detect a change 
in GLT-1 expression in our studies, it is possible that trafficking of existing transporters 
could contribute to the changes we observed. Alternatively, decreased extracellular 
volume contributes to the observed decrease in glutamate transporter current decay 
kinetics observed during development (Thomas et al., 2011) and thus may also play a role 
in epilepsy, where the extracellular space is reduced and known to contribute to 
hyperexcitability (Hochman, 2012). Finally, the rapid buffering of glutamate observed 
following SE may also be facilitated by the increase in gap junctions between astrocytes 
(Takahashi et al., 2010). Indeed, recent work in animals with Cx43 and Cx30 deleted 
from astrocytes, and consequently no gap junctions between astrocytes, demonstrated that 
the decay time constant of the glutamate transport current was significantly slowed, 
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consistent with the notion that extensive networks are essential for proper buffering of 
glutamate (Pannasch et al., 2011). Thus, the maintenance of extensive networks of 
coupled astrocytes could very well be viewed as an essential mechanism for dampening 
excitability in epileptic networks. 
 
Glutamate Receptor Expression 
Astrocyte function depends in part on cell surface receptor expression. Astrocytes 
in juvenile animals and in cell culture have been shown to express nearly every  
transmitter receptor as their neuronal counterparts, including metabotropic and ionotropic 
glutamate receptors; for review see (D'Antoni et al., 2008; Kimelberg, 1995; Lalo et al., 
2010). In brain slices obtained from juvenile animals, the functional expression of a-
amino-3-hdroxy-5-methyl-4-isoxazolepropionic acid (AMPA) (Jabs et al., 1994; 
Schroder et al., 2002; Seifert et al., 2004; Seifert et al., 1997) and N-methyl-Daspartate 
receptors (NMDA) (Serrano et al., 2008; Steinhauser et al., 1994) have been described. 
Expression for group I mGluRs is increased in reactive astrocytes 1 week after 
SE (Aronica et al., 2000), in human MTLE (Notenboom et al., 2006), and in reactive 
astrocytes following neuronal injury (Ferraguti et al., 2001; Ulas et al., 2000), however, 
the electrically passive, GFAP-expressing, protoplasmic astrocyte of the adult 
hippocampus does not express ionotropic glutamate receptors under basal conditions. 
Interestingly, kainate receptors (KARs) and NMDA receptors are expressed in reactive 
astrocytes following ischemia in adult animals (Gottlieb and Matute, 1997; Krebs et al., 
2003). Furthermore, two recent reports have demonstrated that the protoplasmic GFAP+ 
astrocyte of the cortex acquires electrophysiological responses to kainate application 
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following ischemic insult or within an Alzheimer’s disease model, again suggesting 
possible KAR expression in response to injury (Peters et al., 2009; Wang et al., 2008). 
Interestingly, preliminary immunohistochemical studies from our laboratory suggests that 
following SE, astrocytes begin to express KAR subunits (Vargas et al., 2006). The 
modulating role of KARs and their unique ability to couple to G-proteins makes this 
family of glutamate receptor an important component of CNS function. It is currently 
unknown what functional role KARs expressed in astrocytes following KAinduced SE 
play in the disease process of epileptogenesis. However, it is enticing to hypothesize that 
increased calcium signaling and subsequent gliotransmission mediated in part by the 
pathological expression of ionotropic KARs and increased expression of mGluRs in 
reactive astrocytes could cause the synchronization of neurons thus contributing to 
hyperexcitability. 
 
Blood-Brain Barrier Disruption Following SE 
Astrocytes form close associations with the endothelial cells of capillaries and 
help maintain proper function of the blood brain barrier (BBB). Disruption of the BBB is 
often observed in epileptic brain regions, but has generally been thought to result from 
seizure activity, rather than contribute to the generation of seizures. A body of clinical 
and experimental evidence now suggests that opening of the BBB triggers a chain of 
events that may contribute to the processes underlying epileptogenesis. Van Vliet and 
coworkers have demonstrated that pronounced levels of BBB leakage occur during the 
acute and latent phases following SE in humans and rats (van Vliet et al., 2007). In 
addition, following BBB disruption, uptake of the serum protein albumin by astrocytes 
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through TGF- receptors has been associated with reactive gliosis (Ivens, Kaufer et al. 
2007). Studies in cultured astrocytes from rat brains show that albumin induces calcium 
signaling (Nadal et al., 1995) and that TGF-B receptor activation causes a down 
regulation of KIR channels (Perillan et al., 2002), suggesting that albumin can directly 
modulate astrocyte functions and enhance excitability. Together these data suggest that 
disruptions of the blood brain barrier may directly contribute to processes underlying 
epileptogenesis through astrocyte-mediated mechanisms (Ivens et al., 2007). 
It is also important to note that changes in BBB permeability following SE and 
other insults may also have significant consequences for delivery of pharmacotherapies 
and drug-resistant epilepsies (Loscher and Potschka, 2005). For instance, increased 
expression of multidrug-resistance-associated proteins (MDPs) in endothelial cells of 
blood vessels in the brain following seizures has been implicated as a possible 
mechanism in drug-resistant epilepsies. In chronic epilepsy, increased levels of MDPs  
are thought to facilitate the efflux of antiepileptic drugs such as carbamazepine and 
valproate, thereby preventing the accumulation of therapeutic levels of antiepileptic drugs 
in brain tissue (Loscher, 2007). One study demonstrated that increased expression of 
MDPs in reactive astrocytes and blood vessels in the hippocampus occur immediately 
following electrically evoked status epilepticus (SE) in the rat, indicating that changes in 
MDP expression may occur earlier than initially thought (van Vliet et al., 
2005). Furthermore, increased expression of MRPs during the acute and chronic phase 
was also accompanied by decreased levels of an administered ASD, phenytoin (PHT). 
These results suggest that the development of pharmacoresistant epilepsy via the 
increased expression of MRPs may be initiated after a single bout of SE and should be 
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taken into account when considering potential therapeutic interventions aimed at 
disrupting the process of epileptogenesis. 
Additionally, reductions in MCT1, a key BBB carrier molecule for 
monocarboxylates and amino acids, have been observed on the endothelial cell 
membrane of microvessels in the hippocampus of human patients with TLE (Lauritzen et 
al., 2011) as well as two rodent models of SE (Lauritzen et al., 2012b). Reduced levels of 
MCT1 in the epileptogenic hippocampus may impair the uptake of monocarboxylates 
resulting in decreased concentrations of blood-derived fuels, such as ketone bodies, 
which could contribute to enhanced seizure susceptibility. Intriguingly, the transport of 
drugs such as valproic acid across the blood brain barrier is also facilitated by MCT1. 
Thus, concentrations of anti-seizure drugs in the MCT1-deficient epileptogenic 
hippocampus may be severely reduced, representing a possible explanation for 
pharmacoresistance in TLE (Lauritzen et al., 2012b). 
Brain inflammation occurs as a consequence of seizures and is intimately linked 
to changes in BBB permeability. Reactive astrocytes have been identified as key players 
in the mechanisms involved in CNS inflammation (Aronica et al., 2012). Indeed, mRNA 
of inflammatory mediators are induced within 30 minutes of SE onset (De Simoni et al., 
2000) and upregulation of astrocyte genes related to immune and inflammatory responses 
persists for up to 1 week following SE (Gorter et al., 2006). It is now recognized that a 
myriad of immune responses, many of which are mediated by astrocytes, can occur as a 
consequence of seizure activity and may contribute to the development of epilepsy. A 
more complete discussion of these topics are included in this special issue (see Carson 
and Fabene’s reviews). 
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Increased Expression of Adenosine Kinase Following SE 
In addition to the list of the changes in astrocytes following SE, alterations in the 
astrocyte-mediated adenosine/adenosine kinase system have shown intriguing potential as 
a target in the prevention and treatment of epilepsy. For over 40 years, adenosine has 
been recognized as an endogenous anticonvulsant. Adenosine levels are elevated in 
patients following seizures, suggesting that adenosine is released during a seizure and 
may mediate seizure termination (Boison, 2005). Astrocytes regulate adenosine levels via 
the production of the enzyme adenosine kinase (ADK) and during epilepsy, reactive 
astrocytes produce increased levels of ADK. Studies from transgenic animals that have 
increased expression of ADK in the brain show that ADK overexpression leads 
thedevelopment of spontaneous seizures and mortality following KA-induced SE, 
presumably due to a reduction in adenosine (Li et al., 2008). Furthermore, SE may cause 
an imbalance of adenosine/ADK that leads to epileptogenesis. Gouder et al. (2004) 
demonstrated at ADK is increased in reactive astrocytes around 1 week post-SE, prior to 
the development of spontaneous seizures. Intriguingly, reduction of ADK in the brain can 
prevent the development of spontaneous seizures following KA-induced SE and prevents 
cell death, indicating that ADK reduction confers a neuroprotective effect following 
status (Li et al., 2008). Recently Theofilas et al. demonstrated that an antisense viral 
approach to modulate astrocytic ADK expression was able to trigger or prevent seizures 
in mice, providing the first line of evidence that gene therapy may be successfully be 





Changes in Astrocyte Calcium Signaling After SE 
While astrocytes do not exhibit prominent electrical excitability as do neurons, 
they are able to dynamically regulate calcium using internal stores (Charles et al., 1991; 
Cornell-Bell et al., 1990; Finkbeiner, 1992). Calcium transients in astrocytes occur in 
response to the activation of g-protein coupled receptors (e.g. mGluRs) and are thought to 
modulate the release of a number of gliotransmitters that could influence synaptic 
function (Aguado et al., 2002; Araque et al., 1998; Fellin et al., 2004; Halassa and 
Haydon, 2010; Parpura and Haydon, 2000; Pasti et al., 1997; Shigetomi et al., 2008). 
Consistent with effective synaptic modulation, astrocytic calcium transients have been 
shown to correlate with structured neuronal network activity (Aguado et al., 2002; Kuga 
et al., 2011; Winship et al., 2007). These observations naturally lead to the question of 
potential changes in astrocytic calcium dynamics during and following SE and how any 
changes might affect neural network function. Astrocyte calcium dynamics and SE have 
been studied in only a couple of papers to date (Ding et al., 2007) (Smeal et al., In press). 
Ding et al. used two-photon microscopy to study cortical astrocytic calcium dynamics in 
vivo using a pilocarpine model of SE (Ding et al., 2007). They found that astrocytic 
calcium activity increased during and after SE. Interfering with the increase in calcium 
activity in astrocytes that followed SE was neuroprotective, suggesting that glutamate 
release from astrocytes was contributing to excitotoxic cell death following SE (Ding et 
al., 2007). 
Recent work from our laboratory using two-photon microscopy and a fast 
scanning technique showed that calcium waves mediated by the astrocytic syncytium in 
the CA3 region of the hippocampus can be very fast and widespread in vitro (Smeal et 
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al., In press). This fast wave activity was much reduced in brain slices prepared from 
juvenile rats that experienced SE induced with kainic acid. Therefore, based on these two 
studies, calcium dynamics in reactive astrocytes following SE appear to be altered. The 
functional consequences of these changes in the context of epileptogenesis however, 
remains to be determined. 
One of the primary difficulties in studying astrocyte calcium dynamics related to 
SE is the inability to bulk load calcium indicating dyes in brain slices obtained from the 
older animals that are used in the models of SE. The labeling of cells in vitro using the 
acetoxymethyl (AM) ester calcium indicator dyes becomes much more difficult as the 
animals age past a few weeks (Peterlin et al., 2000; Reeves et al., 2011). Transfection of 
protein calcium indicators using viruses is a potential solution, but has the drawback of 
causing astrocytes to become reactive independent of the insult that causes the SE 
(Ortinski et al., 2010). In order to bypass these loading problems, we have recently used 
the in utero electroporation technique (Chen and LoTurco, 2012; Gee et al., 2011; 
LoTurco et al., 2009) to introduce genetic calcium indicators into animals that are 
subsequently used in the standard SE animal models. Using plasmids that contain 
modifications to introduce the genetic calcium indicator (GCaMP-3) into the genome and 
subsequently target it to the cell membrane (Shigetomi et al., 2011) has resulted in well-
labeled astrocytes in a number of brain regions including the hippocampus (Figure 
2). Calcium transients can be detected even in the fine processes (Figure 2). Future 
experiments will study both the potential changes of calcium activity within the fine 
structure of individual astrocytes and in the calcium dynamics of large networks of 
astrocytes following SE and during the process of epileptogenesis. 
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Disease Modifying Therapies Targeting Astrocytes 
The vast majority of anti-seizure (ASD) drugs target ion channels and receptors 
that directly modulate neuronal function (Bialer and White, 2010; White et al., 2007). 
While this approach can confer seizure control to a majority of patients with epilepsy, it 
is estimated that between 25-35% of patients do not have their seizures adequately 
controlled with existing ASDs and the side effects of these drugs also negatively impact 
the quality of life of patients with epilepsy. Thus, novel ASDs that target inflammation 
and as a consequence, reactive astrocytes, may provide viable approaches to seizure 
control. Indeed, there is currently a clinical trial investigating the ability of VX-765, a 
caspase-1 inhibitor that prevents the production of IL-1B, to reduce seizures in patients 
with refractory partial seizures. This is the first clinical trial designed to target 
inflammatory processes in patients with epilepsy and a positive outcome will set the stage 
for novel therapeutic approaches for the treatment of existing seizure disorders. 
There is currently no strategy to prevent the development of epilepsy in patients at 
risk following a CNS insult such as SE. However, initial work with VX-765 in rodents 
suggested that this compound may possess disease modifying properties that could alter 
the development of epilepsy (Ravizza et al., 2008). Furthermore, the increase in 
experiments that study the function of astrocytes following SE has opened the door for 
the development of novel compounds or approaches for targeting astrocyte function in an 
effort to interfere with the process of epileptogenesis. In addition to the VX-765 studies 
already discussed, the manipulation of the adenosine kinase system as described in this 
issue by Boison and colleagues may prove to be an important new therapeutic direction. 
Likewise, as more information is gleaned about the role of reactive astrocytes in the 
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progression of epilepsy, the more opportunities we will have for interfering with the 
process of epileptogenesis. 
 
Conclusions  
SE results in rapid structural and functional changes to not only neurons, but 
astrocytes as well. Numerous studies performed in resected epileptic tissue and in chronic 
models of epilepsy have noted many changes in astrocyte function that might contribute 
to seizure activity. However, less is known about early changes in function in astrocytes 
following SE and to what extent astrocytes prevent or contribute to the development of 
epilepsy following SE. Ideally, understanding the wide array of astrocyte functions will 
give us clues as to how to exploit those processes that dampen excitability, such as 
glutamate uptake, gap junctions, and potassium buffering, and how to minimize those 
processes that contribute to network excitability, such as decreased expression of 
aquaporins and secretion of cytokines and gliotransmitters. The development of new tools 
for wide scale imaging of networks of neurons and astrocytes with genetically encoded 
calcium indicators will undoubtedly contribute to our quest for disease modification and 
prevention of acquired epilepsy. 
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Figure 1.1. Reactive astrocytes are present in the hippocampus 1 week following 
KA-induced SE. 
 (A) Immunoreactivity for GFAP is observed throughout the hippocampus and cortex in 
horizontal brain sections from both control and KA-treated rats. dg = dentate gyrus, ecx = 
medial entorhinal cortex. (B) Close up of CA1 and stratum radiatum from the area 
indicated by the white box in (A). Sections from KA-treated rats (right) show 
characteristics typical of reactive astrocytes including a hypertrophied morphology and 
an increase in the immunoreactivity for GFAP. Scale bar, 50 lm. (C) Western Blot of 
crude hippocampal membrane fractions from control (Ct) and kainate-treated (Kt) 
animals probed with an antibody directed against GFAP. Actin served as a lane loading 
control. (D) Densitometry values of immunoreactivity for GFAP from kainate-treated 
samples (n = 6) were found to be significantly increased compared to control (n = 8) 
samples (⁄⁄p < 0.0001, Student’s t test). Figure reprinted from (Takahashi et al., 2010) 






Figure 1.2. Ca2+ transients recorded at high resolution in the soma and throughout 
the processes in an astrocyte expressing Lck-GCaMP3 are observed in a series of 
images extracted from a movie using a standard x-y raster. 
Changes in fluorescence as a consequence of increased Ca2+ are highlighted in pseudo-
color and superimposed on the mean image of the movie. At time 0.0 s, there is activity 
throughout the astrocyte. Time 66.9 to 74.3 s shows a slow wave moving from the main 
processes to the soma. The final two panels demonstrate isolated Ca2+ transients in the 






CHALLENGES FOR STUDYING THE TRIPARTITE SYNAPSE 
 
As the previous chapter discussed, astrocytes, the main cell type responsible for 
the maintenance of brain homeostasis, become reactive and undergo widespread changes 
after status epilepticus (SE). The functional significance of changes that accompany 
astrogliosis during the development of temporal lobe epilepsy (TLE) is still very unclear, 
and it is currently unknown to what extent reactive astrocytes might contribute to, or 
prevent, seizure generation in TLE. Understanding the role of astrocytes during the 
process of epileptogenesis is key to providing a better grasp on the changes that take 
place during the development of epilepsy and for designing new therapies for treating 
individuals at risk for developing acquired epilepsy. The overall goal of this dissertation 
was to understand the functional alterations in astrocytes during TLE and I focused on 
investigating how Ca2+ signaling might be altered in reactive astrocytes in the kainic 
acid-induced status epilepticus model of human mesial temporal lobe epilepsy. 
Although astrocytes express numerous ligand and voltage gated ion channels, 
receptors, and transporters, they do not respond to stimulation with significant changes in 
membrane potential (Takahashi, Vargas, & Wilcox, 2010). As a result, the 
electrophysiological methods that are commonly used to monitor neuronal activity are 
not particularly useful for studying astrocyte activity. Astrocytes do, however, exhibit 
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dynamic changes in intracellular calcium that respond to neurotransmitters and evoked 
neuronal activity. Measuring Ca2+ dynamics in astrocytes and linking these events to 
neural activity has been a substantial challenge for the field and has required the 
development of new methods to monitor activity in physiologically-meaningful contexts 
(Bazargani & Attwell, 2016; Nedergaard & Verkhratsky, 2012). Most early 
investigations of astrocyte Ca2+ activity were based on bulk-loaded membrane-permeable 
chemical Ca2+ indicators. Fluo4-AM and Oregon Green BAPTA1-AM, the most popular 
chemical indicators used to image Ca2+ activity in astrocytes, allow imaging the somatic 
region and the larger proximal processes of astrocytes but do not diffuse into the very 
thin processes that closely appose neuronal structures. Therefore, it is likely that many 
early investigations of astrocyte Ca2+ signaling missed important signals in the fine 
processes. Furthermore, synthetic dyes are particularly difficult to load into adult or 
pathological tissue, limiting their use exclusively to young, healthy tissue.  
The recent availability of genetically encoded calcium indicating proteins 
(GECI’s) has provided the opportunity to monitor Ca2+ activity in cells from healthy and 
diseased tissue. Several variants of the GFP-based Ca2+ sensor GCaMP have been used to 
obtain important information about Ca2+ states in both neurons and astrocytes (Chen et 
al., 2013; Li, Agulhon, Schmidt, Oheim, & Ropert, 2013; Rose, Goltstein, Portugues, & 
Griesbeck, 2014). Furthermore, the inclusion of a membrane-tethering domain, Lck, 
increases the level of GCaMP expression near the plasma membrane, enabling the 
monitoring of Ca2+ signals in previously inaccessible fine processes (Gee et al., 2015; 
Haustein et al., 2014; Shigetomi, Bushong, et al., 2013; Shigetomi, Kracun, & Khakh, 
2010; Shigetomi, Patel, & Khakh, 2016). Monitoring astrocyte activity using GECI’s, it 
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has become clear that astrocytes exhibit dynamic increases in intracellular Ca2+ 
throughout their entire cell bodies, but especially in the fine processes. Distinct types of 
astrocytic Ca2+ signals have been described that involve the release of Ca2+ from internal 
stores as well as the activation of Ca2+-permeable membrane channels (Petravicz, Fiacco, 
& McCarthy, 2008; Rungta et al., 2016; Shigetomi, Jackson-Weaver, Huckstepp, O'Dell, 
& Khakh, 2013).  
The most distinguishing feature of astrocytes in the hippocampus is their highly 
complex, bushy morphology. This complex morphology enables astrocytes to penetrate 
all areas of the neuropil and maintain intimate associations with the axons and dendrites 
that comprise synapses. The concept of the “tripartite synapse” was coined in order to 
describe the role of the astrocyte processes as morphological and functional partners of 
the synapse (Araque, Parpura, Sanzgiri, & Haydon, 1999; Perea, Navarrete, & Araque, 
2009). This term proposes that the synapse should take into account the role of the 
astrocyte, as well as the pre- and postsynaptic neuronal elements. 
The close proximity and complex interactions between astrocytes and neurons 
have made it clear that a complete understanding of brain circuit function relies on the 
ability to monitor and differentiate activity in both cell types. However, many questions 
remain about the functional relationships between astrocytes and neurons at synapses, 
how different astrocyte subtypes encode information in Ca2+ signals, and how Ca2+ 
signaling might be altered in brain disorders such as epilepsy.  
The following chapter in this dissertation describes the development and 
characterization of a unique genetic tool to differentiate and color code astrocytes and 
neurons during Ca2+ imaging experiments. Furthermore, the development of this plasmid 
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lays the groundwork for experiments, discussed in Chapter 4, examining alterations in 
calcium signaling in reactive astrocytes during the development of epilepsy in the rat 
kainic acid-induced model of TLE.  
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A NOVEL PLASMID FOR GENETICALLY DIFFERENTIATING 




Elucidating the relationship between astrocytes and neurons is a fundamental 
challenge to understanding how the myriad of astrocyte subtypes contributes to normal 
synapse function and neurological disorders. Most genetic approaches for studying 
astrocyte-neuron interactions rely on selective targeting of proteins to either astrocytes or 
neurons. Currently, no single tool exists capable of differentiating astrocytes and neurons 
in real time. To address this gap in research tools, we developed a novel transposable 
transgene, the Neuron/Astrocyte Specified Transgene by in utero electroporation 
(NASTIE). The NASTIE transgene is composed of a strong promoter driving expression 
of the genetically encoded calcium indicator protein, Lck-GCaMP6f, and a red 
fluorophore, tdTomato; the tdTomato coding region is flanked by loxP sites. Downstream 
of tdTomato is the blue fluorescent protein, Cerulean. The transgene also carries a 
Synapsin I promoter driving Cre expression. When cells destined to populate the rat 
hippocampus are transfected using in utero electroporation, only cells that express 
Synapsin I undergo Cre-mediated excision of the tdTomato coding region and express 
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Cerulean instead; any cell that does not normally express Synapsin I will continue to 
express tdTomato. We evaluated NASTIE transfected rat hippocampi using 2-photon 
imaging and immunohistochemistry and show the utility of this tool in capturing high-
resolution images of the close morphological associations of astrocytes and neurons. 
Next, we recorded subcellular calcium activity in both astrocytes and neurons, 
demonstrating the use of NASTIE to investigate functional aspects of calcium signaling in 
transfected cells. We have created a novel tool that allows for distinguishing the fine 
processes of astrocytes from dendritic processes of neurons and for monitoring changes 
in calcium activity in astrocytes and neurons in the rat brain. The modular design of the 
transgene makes it possible to swap in different promoters or indicators for customized 
application of the tool. Thus, this versatile genetic tool could be used to elucidate the 
relationships between different combinations of cells of interest. 
 
Introduction 
In the last few decades, the roles of astrocytes as active partners in neural circuit 
function have rapidly expanded to include the ability to integrate neuronal signals (Di 
Castro et al., 2011; Murphy-Royal, Dupuis, Groc, & Oliet, 2017; Wang et al., 2006), 
regulate neuronal activity(Letellier et al., 2016; Newman, 2003), participate in 
neurotransmission (Brancaccio, Patton, Chesham, Maywood, & Hastings, 2017; Harada, 
Kamiya, & Tsuboi, 2015), and regulate neural plasticity (Murphy-Royal et al., 2015; 
Poskanzer & Yuste, 2016). Astrocytes maintain intimate and dynamic associations with 
neurons, both morphologically and functionally (Haber, Zhou, & Murai, 2006; Medvedev 
et al., 2014; Perez-Alvarez, Navarrete, Covelo, Martin, & Araque, 2014; Theodosis, 
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Poulain, & Oliet, 2008; Ventura & Harris, 1999). A typical protoplasmic astrocyte in the 
hippocampus exhibits an extremely complex, bushy, sponge-like network of processes 
(Bushong, Martone, & Ellisman, 2004; Bushong, Martone, Jones, & Ellisman, 2002). 
Astrocytes communicate through ultrathin distal processes that contact and sometimes 
enwrap synapses (Halassa, Fellin, Takano, Dong, & Haydon, 2007). Functionally, this 
places astrocyte processes in a position to detect, integrate, and shape synaptic activity. 
Practically, it makes investigation of these interactions highly challenging, as visual 
confirmation of real-time activity between the two cells, in an experimental model with 
only one cell labeled, can be almost impossible. The increasing recognition of the role of 
astrocytes in synaptic transmission in the last few decades has led to the concept of the 
tripartite synapse, which reflects the critical role that astrocytes play in synapse function 
(Araque, Parpura, Sanzgiri, & Haydon, 1999). However, the study of astrocyte-neuronal 
networks has been hampered by a lack of tools that facilitate the selective labeling of 
both of these cells. Many unresolved questions remain about the anatomical and 
functional relationships of astrocytes and neurons in the healthy brain, as well in 
neurological and psychiatric disease. Thus, a tool capable of selectively distinguishing 
astrocytes and neurons would be a great benefit to the field. 
Another reason a tool has been difficult to design is the fact that astrocytes are 
electrically-passive, rendering standard electrophysiological techniques ineffective 
(Kimelberg, 2010). Using a genetically encoded calcium indicator (GECI), like the 
GCaMP family of proteins which fluoresce in the presence of calcium, allows us to use 
intracellular Ca2+, a physiologically integral second messenger important to astrocyte 
physiology (Bazargani & Attwell, 2016; Rusakov, 2015), to monitor the activity and 
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intercellular signaling between neurons and astrocytes with subcellular resolution in 
physiologically relevant preparations (Shigetomi, Patel, & Khakh, 2016). GECIs, 
optimized for studying calcium activity in astrocytes, have been particularly useful to 
elucidate the activity of astrocytes in several biological contexts, and have revealed the 
complexity and relevance of the dynamic range of fluctuations of calcium, particularly in 
the fine processes of astrocytes (Shigetomi, Kracun, & Khakh, 2010; Shigetomi et al., 
2016; Srinivasan et al., 2016). Previous studies have employed two strategies for 
expressing GECIs to study astrocyte-neuronal networks brain: 1) use of targeted 
transgenic mouse lines with cell-type specific promoters in combination with conditional, 
Cre-Lox or tetO-tTA, transgenes, delivered by viral infection or by crossing to other 
transgenic mouse lines, to target expression specifically to astrocyte or neurons (Gee et 
al., 2014; Srinivasan et al., 2016; Szokol et al., 2015; Tang et al., 2015); or 2) use of viral 
infection or electroporation to transfect all cells of a brain region with a transgene, 
carrying a strong ubiquitous promoter, and relying on posthoc identification, through 
morphological characteristics or immunohistochemistry, in order to identify cell type 
(Gee et al., 2015; O'Donnell, Jackson, & Robinson, 2016).  
Given that it is not feasible to generate transgenic lines for many of the long 
established neurological disease models in rats, and the insurmountable challenges of 
differentiating processes of astrocytes and neurons using posthoc identification 
techniques, we sought to develop a single tool that can assay physiologically relevant 
signaling in astrocytes and neurons in real-time. This tool, Neuron/Astrocyte Specified 
Transgene by in utero Electroporation (NASTIE), was designed to differentially label 
neurons and astrocytes and allows for the real-time monitoring of calcium transients in 
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both cell types. NASTIE utilizes Cre/lox recombination to differentially express 
fluorescent reporter proteins and reliably labels neurons with Cerulean and astrocytes 
with tdTomato in the hippocampus. The simultaneous labeling of both cell types enables 
high magnification imaging of closely associated astrocyte and neuronal structures. The 
construct can be used to investigate calcium signaling, in astrocytes and neurons, in 
primary neuronal cell culture, organotypic slice cultures, acute brain slices, and in vivo 
with newly developed head-mounted cameras. We designed this tool to be modular, such 
that it is straightforward to substitute new GECIs, as technology advances, or by 
switching the promoter sequences, for another cell-specific promoter, researchers can 
modify the specific interacting cell populations they wish to study. This tool offers a new 
strategy for researchers interested in combining high-resolution visualization and 
identification of astrocytes and neurons combined with the ability to image calcium 
activity in networks of cells in the brain, or any other region of the body, where cells are 




The Lck-GCaMP6f gene was moved into a plasmid harboring inverted terminal 
repeats recognized by piggyBac transposases, pPB.GFP.neo, using Xba1 (5’) and Not1 
(3’) restriction sites. Ires-Lox-tdTomato was cloned from a fragment obtained from Ben 
Xu (Capecchi lab, unpublished) into HindIII and AscI sites. A polylinker containing SpeI 
and PacI was inserted into pPB.GCaMP6-IRES-lox-tdTomato. A loxP site was added to 
the 5’ end of the Cerulean (Addgene# 15214) coding sequence and an SV40 
polyadenylation sequence was added immediately after the stop codon and it was cloned 
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via PCR into PacI and SpeI sites in the polylinker immediately downstream of tdTomato. 
The rat Synapsin I promoter (Gift from Megan Williams, Univ. of Utah, Addgene 
#27232) was cloned before the Cre gene into pBluescript SK+ vector at the NotI site 
using Gibson Assembly Cloning (NEB E5510S).  For Gibson assembly, primers were 
designed using the Gibson primer design application on the NEB website. The Synapsin 
I-cre fragment was cloned into pPB. GCaMP6.IRES.lox.tdTomato.lox.Cerulean to 
complete the NASTIE construct (Figure 3.1). 
 
SH-SY5Y cultures 
To test expression of tdTomato, expression and functionality of GCAMP6f, and 
synapsin specific expression of Cre and subsequent recombination on and expression of 
Cerulean, we transfected the SH-SY5Y cell line. This cell line was previously shown to 
express Synapsin from the endogenous promoter as well as the P2Y ATP receptor 
subclass. We transfect 1x106 cells with ~1 μg of the NASTIE transgene and ~300 ng of a 
plasmid that expressed the piggyBac transposase source using the Amaxa IIb 
electroporator.  Cells were scored for tdTomato expression, Cerulean expression, basal 
levels of GFP fluorescence in the absence of an induced response, as well as 
documenting through live-time lapse imaging, using a Zeiss Axiovert 200M and a 
Hamammatsu ORCA R2, the dynamic increase in GFP fluorescence intensity, indicating 






Primary neuronal cultures 
Primary cultures of cortical neurons were prepared from embryonic (E-18) CF-1 
mice (Charles River, Wilmington, MA), as described previously (Otto, Kimball, & 
Wilcox, 2002). Embryos (Day 18) were removed from anesthetized CF-1 mice and the 
brains were quickly removed from the embryos. Dissected cortical hemispheres were 
gently chopped into small pieces and then incubated 2 min in 15 mL DMEM with 0.25% 
trypsin.  Two mL of heat inactivated horse serum (Invitrogen) was then added and this 
mixture was centrifuged 2 min at 1800 RPM. The supernatant was removed and the 
brains triturated and then spun again for 2 min at 1800 RPM. Cells were resuspended in 5 
mL of Dulbecco's modified Eagle's medium supplemented with 10% horse serum, 10% 
fetal calf serum, 3% glucose, and 2% L-glutamine and strained through a 70 um cell 
strainer (BD Falcon).  Cells were plated at a low density of 100,000 cells/ml on poly-L-
lysine (Sigma) coated coverslips placed in 12 well plates. Cultures were maintained in a 
humidified incubator at 37°C and 5% CO2. When cells were about 70% confluent, the 
cultures were treated with Ara-C (Sigma) 10- 14 μL of a 1 μM stock, usually between 5 
to 6 days after plating.  
Cells were transfected 24 hours after Ara-C treatment with lipofectamine 2000 
(Thermofisher). Each coverslip with cells was placed into 1 well of a 12 well plate in 
Neuronal Incubation media (NIM). The NASTIE plasmid (1 μg) in 50 μL of h-DMEM 
(with 1X GlutaMax (Gibco) buffered with 10 mM HEPES (Gibco)) was mixed with 3 μL 
of lipofectamine diluted in 50 μL of h-DMEM and incubated at room temperature for 15 
min. 100 μL of this solution was then added to the well with the coverslip and incubated 
1 hour at 37C without CO2.  The coverslip was then placed back into the well containing 
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the original conditioned DMEM.  Cells were imaged 24 to 48 hours later (Shepherd et al., 
2006).   
 
In utero electroporation 
Transfection of the embryonic rat brain was accomplished using an established in 
utero electroporation protocol (Gee et al., 2015). In utero electroporation was performed 
on embryonic day (E) 14.5-15.0. The final concentration of DNA plasmid solution was 4 
μg/μl final (2 μg/μl of NASTIE and 2 μg/μl of transposase source). In order to target the 
developing hippocampus, the paddles were rotated across the top of the head with the 
positive electrode placed opposite the injected side, as previously described (Gee et al., 
2015; Navarro-Quiroga, Chittajallu, Gallo, & Haydar, 2007). Animals were weaned from 
the mother on postnatal day (P) 21 and males and females housed separately until used 
for experiments. 
 
Preparation of acute brain slices 
Brain slices were prepared using established techniques (Takahashi, Vargas, & 
Wilcox, 2010). Briefly, electroporated rats were deeply anesthetized using isoflurane and 
decapitated. Brains were rapidly dissected and placed in ice-cold (4 °C) oxygenated 
sucrose Ringer’s solution (95% O2/5% CO2) containing (in mM): 200 sucrose, 26 
NaHCO3, 10 D-glucose, 3 KCl, 3 MgSO4, 1 CaCl2, and 1.4 NaH2PO4. Brains were then 
cut down the midline and glued dorsal side down to the mounting disk of a Vibratome 
tissue slicer (Vibratome, St. Louis, MO). Horizontal brain slices (400 μm) containing 
both the medial entorhinal cortex and hippocampus were cut in oxygenated sucrose 
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Ringer’s solution. Following sectioning, slices were transferred to a holding chamber 
filled with oxygenated artificial cerebrospinal fluid (ACSF; room temperature) containing 
(in mM):  126 NaCl, 26 NaHCO2, 10 D-glucose, 3 KCl, 2 MgSO2, 2 CaCl and 1.4 
NaH2PO4 for at least 1 hour. The normal Ringer’s solution was continuously bubbled 
with 95% O2/5% CO2, the pH was adjusted to between 7.35 and 7.40 with HCl or NaOH, 
and the osmolarity was adjusted to between 300 and 305 mOsm with double distilled 
water or 10X Ringers.  
 
Two-photon imaging 
During imaging, slices were placed in a heated (31°C ± 1) immersion style 
recording chamber (Warner Instruments, Hamden, CT, USA) mounted on a microscope 
stage and perfused with oxygenated ACSF. Two-photon imaging was performed using a 
Bruker 2-photon microscope assembled around a mode-locked laser source emitting 140 
fs pulses at an 80 MHz repetition rate with a wavelength adjustable from 690-1040 nm 
(Spectra Physics). Laser emission wavelengths of 940-950 nm were used to excite 
GCaMP (T. W. Chen et al., 2013; Tian et al., 2009), 1020 nm to excite tdTomato, and 
860 nm to excite Cerulean (Drobizhev, Makarov, Tillo, Hughes, & Rebane, 2011). Full 
field of view images were acquired with an x-y raster scan. We used 20x 0.95 NA 
objective (Olympus, Tokyo, Japan). Emitted photons were bandpass filtered (Semrock, 
Rochester, NY, USA) at (peak/bandwidth): 525/50 nm (GCaMP), 593/46 nm (tdTomato) 
and collected by a wide band (300-650 nm) and low noise photomultiplier tube (H7360-
01; Hamamatsu, Hamamatsu City, Japan). To avoid the “dead zone” on the surface of 





Pharmacological activation of neurons 
To activate neurons in acute brain slice, 500 μM of kainate, a glutamate receptor 
agonist was focally applied to cells. Glass electrodes were pulled from borosilicate glass 
capillaries (Schott #8250 glass, World Precision Instruments, Sarasota, FL) to ~2 μm 
using a micropipette electrode puller (P-97, Sutter Instruments, Novato, CA). The pipette 
was placed ~100 μm or less away from a cell of interest. Receptor agonists were 
delivered by pressure application (200-500ms, ~20 psi) using a picospritzer. Ca2+ activity 
was monitored in a single optical plane and measured by plotting the intensity of a region 
of interest (ROI) over time, after the intensity of the background ROI had been subtracted 
(Jia, Rochefort, Chen, & Konnerth, 2011). 
 
Immunohistochemistry and quantification 
On P9, P35, P60, electroporated rats were deeply anesthetized with sodium 
pentobarbital (25mg/kg, i.p.) and transcardially perfused with ice cold PBS followed by 
4% paraformaldehyde diluted with PBS. Brains were removed and postfixed for 24 hours 
in a solution containing 20% sucrose and PBS. Frozen coronal sections were cut at 35 μm 
on a cryostat and mounted onto glass slides (Superfrost Plus Micro Slide, VWR). 
Sections were incubated for 48 hours with mouse anti-NeuN (1:100; Millipore MAB377) 
and rabbit anti-GFAP (1:2000; Millipore AB5804) diluted in Cyto-Q Immuno Diluent 
and Block (Innovex Biosciences). The primary antibody was localized with Alexa Fluor 
647 goat anti-mouse and anti-rabbit IgGs (respectively) (1:200; Invitrogen A21235, 
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A21245) for 2 hours at room temperature. Following antibody labeling, slides were 
mounted with ProLong Gold Antifade (P36930 Invitrogen, Carlsbad, CA, USA). All 
imaging was performed with a Leica TCS SP5 confocal microscope equipped with a 20x 
objective. For quantification of colocalization of tdTomato/Cerulean and GFAP/NeuN, 
512 x 512 pixel images were taken of the CA1, CA3, and DG regions of the 
hippocampus. Images were acquired in 2μm z stacks. Quantification of cells displaying 




Wildtype rats on P9, P20, P35, and P60 were deeply anesthetized with 
pentobarbital, decapitated, and the hippocampi dissected. Protein expression of Synapsin 
I was quantified by Western Blot analysis. Briefly, hippocampi were rapidly isolated, 
frozen immediately on 2-methylbutane on dry ice, and stored at -80°C until further 
processing. The hippocampi were homogenized in 10 µl of lysis buffer (25mM Tris-HCl, 
150mM NaCl, 1mM EDTA, 1% Igepal CA-630, 5% glycerol, protease inhibitors 
(cocktail tablet, Roche), and 1mM sodium orthovanadate) per mg of tissue and the 
supernatant was collected. Total protein concentration was measured by BCA protein 
assay (Pierce) and 10 µg of total protein was subjected to electrophoresis using 
polyacrylamide gel (4-12% Bis-Tris gel, NuPAGE™, Invitrogen) under denaturing 
conditions. The proteins were transferred to a PVDF membrane, and Synapsin I and 
Actin were detected by chemiluminescence (NEL105001EA, PerkinElmer) using rabbit 
polyclonal antibodies against Synapsin I (1:25000; Invitrogen 51-5200) and actin 
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(1:250,000; Sigma A2103) followed by HRP-conjugated secondary antibody (1:3000; 
Invitrogen 65-6120). Densitometric analysis of protein levels was performed using 
ImageJ software (NIH). 
 
Spontaneous calcium event selection and data analysis 
In order to minimize the effect of region of interest (ROI) selection bias on our 
results, ROI selection was accomplished using GECIQuant scripts from the Khahk 
laboratory (http://www.physiology.ucla.edu/Labs/khakh/astrocytetools.htm) (Srinivasan 
et al., 2015). Automatic time-series event detection was accomplished with custom-
written MATLAB (MathWorks, Natick, MA, USA) scripts. ΔF/F0 time-series plots were 
generated for each ROI by averaging F values of each pixel at each time point and using 
the median fluorescence of all image frames as the baseline fluorescence (F0). The ΔF/F0 
trace for each selected ROI was filtered with an order-3 one-dimensional median filter. 
The noise floor was defined as the median of the lower 30th percentile of fluorescence 
intensity values. The event threshold was set to three standard deviations above the noise 
floor with a ΔF/F0 of at least 30%. Using this threshold, event peaks were found with the 
findpeaks command in MATLAB. Events were eliminated if the time points adjacent to 
the event peak were not large enough (i.e., did not have a ΔF/F0 of at least 60% of the 
event threshold). Event durations were calculated as the time between the troughs before 
and after each event peak. The troughs before and after each peak were detected 
automatically and were defined as, respectively, the last or first data points before or after 





Statistical analyses were performed with GraphPad Prism 6 (GraphPad Software, 
La Jolla, CA, USA). We used Student’s t-test to compare means of normally distributed 
data. The Kolmogorov-Smirnov test (KS-test) was used to compare cumulative 
distributions. Western Blot data were compared using ANOVA with Tukey’s Multiple 
Comparison test. Statistics are presented as mean ± SEM unless otherwise noted. A 
significance level of p < 0.05 was used.    
 
Results 
NASTIE, a Lck-GCaMP6f harboring plasmid for differentially 
labeling astrocytes and neurons following IUE 
Genetically encoded calcium indicators offer a number of advantages over 
organic calcium indicators for studying calcium activity in the brain (Akerboom et al., 
2013). GCaMP6f is the superior GECI, as it has faster kinetics and higher signal to noise 
than its predecessors (Tian et al., 2009). Furthermore, the plasma membrane targeting 
Lck-GCaMP is ideal for studying astrocyte calcium signaling as it reliably reports 
calcium signals in near membrane regions and fine processes (Shigetomi et al., 2010). A 
transgenic mouse line expressing Lck-GCaMP6f in astrocytes exists (Srinivasan et al., 
2016). However, rat models are sometimes preferable to mouse models. In particular, rat 
models of Parkinson’s disease and the development of epilepsy following status 
epilepticus, closely mimic particular aspects of human conditions and are critical tools for 
translational neuroscience research (Duty & Jenner, 2011; Gibbons, Smeal, Takahashi, 
Vargas, & Wilcox, 2013). Viral vectors are often used to deliver GCaMP to rat brains, 
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but the need for invasive injections near the imaging site and low carrying capacity of 
viral vectors (as discussed in (Gee et al., 2015)) renders this approach suboptimal in some 
settings. As an alternative, in utero electroporation (IUE) is a proven method for 
transfecting cells in the rat brain without strict limitations on transgene size or invasive 
injections associated with viruses. IUE has been used to transfect populations of both 
astrocytes and neurons in the brain and can be combined with piggyBac transposon 
systems to ensure stable integration in to the genome of the transfected cell. Integration 
facilitates transmission of the transgene to the entire lineage of transfected progenitor and 
stable expression of genes throughout the lifespan of the cells in the animal (F. Chen & 
LoTurco, 2012; Gee et al., 2015). However, baseline fluorescence from GCAMP protein 
is dim due to low concentrations of resting calcium in cells. To address this, we 
previously developed a tool kit of plasmids for IUE where we coexpressed tdTomato, a 
bright red fluorescent protein, with GCaMP under the control of the same promoter to 
enable detection of electroporated cells (Gee et al., 2015). Because transfection by 
electroporation is not specific to any one cell type, fluorescent reporters can also aid in 
determining the identity of the transfected cells by delineating a cell’s morphology, since 
the reporter proteins will freely diffuse throughout the entire cytoplasm of cells, including 
the fine processes. However, we found that a single fluorophore was insufficient because 
it can be difficult to distinguish between astrocyte and neuronal processes labeled with 
the same fluorophore. In light of this, we designed NASTIE to conditionally change 
expression from tdTomato to Cerulean in cells that express the neuronal protein Synapsin 
Ia.  
The NASTIE transgene is a piggyBac transposable element, flanked on both sides 
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with inverted terminal repeats (iTR) (Figure 3.1). The piggyBac transposase recognizes 
these iTRs and excises NASTIE from the plasmid and inserts it into a chromosome in the 
transfected cell. NASTIE also harbors GCaMP6f, which is targeted to the membrane with 
the Lck tag, and is driven by the strong ubiquitous promoter cytomegalovirus early 
enhancer/chicken beta actin (CAG) (Niwa, Yamamura, & Miyazaki, 1991). Expression of 
tdTomato (Shaner et al., 2004), is also under the control of the CAG promoter via an 
internal ribosomal entry site (IRES). IRES is a bicistronic sequence that allows for 
simultaneous expression of two proteins individually but from the same RNA transcript. 
The tdTomato gene is flanked by lox2272 sites (Suzuki, Inui, & Yukawa, 2007). The 
transgene also contains the gene for the blue fluorescent protein, Cerulean, downstream 
of tdTomato (Shaner, Steinbach, & Tsien, 2005). The pan neuronal specific rat promoter, 
Synapsin I (Hoesche, Sauerwald, Veh, Krippl, & Kilimann, 1993) drives expression of 
Cre, so that Synapsin I expressing cells transfected with NASTIE will also express Cre 
and  Cre-mediated recombination will excise the tdTomato coding region, placing  the 
Cerulean gene directly downstream of the IRES. Thus, in cells that express Synapsin I, 
Cre-mediated recombination results in the removal of tdTomato and the expression of 
Cerulean. 
The entire NASTIE transgene is 12,426 base pairs and is flanked by terminal 
repeat sequences recognized by the piggyBac transposase. We used IUE to cotransfect 
the NASTIE transposon and a second plasmid that encoded the transposase, into 
progenitor cells in the rat hippocampus. We tested both wildtype piggyBac transposase 
(pbase) and hyperactive piggyBac transposase and observed nearly two-fold increase in 
the number of cells labeled by hyperactive piggyBac transposase (Figure 3.2). Therefore, 
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we opted to use the hyperactive piggyBac transposase when using IUE to express 
NASTIE. 
 
Expression of NASTIE in cell culture and rat  
hippocampus demonstrates intact transgenes 
We initially tested the NASTIE transgene by transfecting the Synapsin I-
expressing human neuroblastoma cell line SH-SY5Y (Figure 3.3a-c). We observed 
expression of tdTomato and Cerulean in cells, indicating that tdTomato expression and 
Synapsin induced Cre-mediated recombination and subsequent Cerulean expression 
occurred as designed. We also observed a population of cells that demonstrated both 
tdTomato and Cerulean fluorescence, likely due to perdurance of the tdTomato protein 
and nascent expression of Cerulean, following Cre-lox recombination. These data 
provided initial confirmation of functional expression of tdTomato, Cre, and Cerulean 
genes from the NASTIE transgene. We also validated the functionality of the GECI, 
GCaMP6f, by transfecting primary neuronal cultures with NASTIE. Primary neuronal 
cultures express Synapsin and display high frequency spontaneous recurrent 
synchronized bursting behavior. The average magnitude of spontaneous calcium 
transients in primary cultured neurons was 258.34% ΔF/F0 ± 24.3 and the frequency 
(number of events in 100 seconds) was 15.3 ±1.2 (n = 30 ROIs in 6 cells) (Figure 3.3d). 
These data validate the expression and function of the GCaMP6f gene in cells that 
underwent synapsin-dependent Cre-mediated recombination to express Cerulean. 
NASTIE can be transfected in the rat brain using IUE to label astrocytes and 
neurons. High resolution 2 photon imaging in acute brain slices prepared from NASTIE 
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rats revealed labeling of two predominant cell types, marked by bright expression of 
tdTomato and Cerulean throughout their cellular compartments and fine processes 
(Figure 3.4). TdTomato positive cells were most frequently observed in the stratum 
radiatum (SR) of the hippocampus and displayed unambiguous morphological features of 
astrocytes, marked by a relatively small soma surrounded by heavily branched, fine 
processes. Cells labeled with Cerulean were most frequently observed in the cell body 
layer of the hippocampus and demonstrated characteristic morphological features of 
pyramidal neurons, including triangular shaped cell bodies and a large proximal dendrite 
projecting into the SR.  
 
Developmental time course of NASTIE expression in 
hippocampal cells 
We also validated the types of cells expressing Cerulean and tdTomato using 
immunohistochemistry in NASTIE transfected rat brains harvested from P9, P35, and P60 
animals. To identify astrocytes, we used an antibody against the astrocyte marker, glial 
fibrillary acidic protein (GFAP) (Figure 3.5a). To positively identify neurons, we used an 
antibody against the neuronal antigen NeuN (Figure 3.5b). Colocalization of GFAP and 
NeuN with tdTomato and Cerulean-positive cells was quantified at each time point. 
Colocalization analysis of Cerulean-positive cells with NeuN revealed that the majority 
of cells that expressed Cerulean were also positive for NeuN staining (P9 = 88.1% ± 4.7; 
P35 = 79.13%  ± 1.9; P60 = 71.26% ± 4.42; n =4-5; Figure 3.5e). Interestingly, a subset 
of Cerulean-positive cells at P35 (9.01% ± 2.06; n = 4; Figure 3.5e), P35 (21.25% ± 1.88; 
n = 4; Figure 3.5e) and P60 (25.50% ± 2.45; n = 4; Figure 3.5e) were also found to 
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coexpress with GFAP (Figure 3.5d), suggesting that Cre-dependent recombination of 
tdTomato had occurred in a subset of astrocytes, allowing for expression of Cerulean.  
Colocalization of tdTomato with transfected cells showed a complex pattern 
during development. At the earliest time point observed, P9, less than half of tdTomato-
positive cells colocalized with the astrocyte marker GFAP (44.9 ± 1.20; n= 4; Figure 
3.5d). The remaining tdTomato cells at this time-point colocalized with NeuN (52.05% ± 
6.37; n = 4; Figure 3.5d), suggesting that the transgene had not yet undergone Cre-
dependent recombination in neurons or the Cerulean protein had not yet accumulated to 
the threshold level necessary for visualization. However, at the P35 and P60 time-points, 
approximately 90% tdTomato-positive cells colocalized with GFAP. These data suggest 
that tdTomato expression is a reliable marker of astrocyte cell identity. Taken together, 
the data indicate that the NASTIE transgene preferentially labels neurons with Cerulean 
and astrocytes with tdTomato in mature (P35 and P60) rats, making it a useful tool for the 
identification of astrocytes, neurons, and their processes in the hippocampus. 
 
Synapsin promoter activity of NASTIE corresponds to the  
developmental expression of endogenous synapsin I in 
the rat hippocampus 
We chose the rat Synapsin I promoter to drive Cre-mediated recombination due to 
well-reported specificity for achieving pan neuronal expression throughout the brain 
(Hoesche et al., 1993). We observed many tdTomato-positive cells in the stratum 
pyramidale layer of the hippocampus that showed clear morphological features of 
pyramidal neurons at the P9 time point (Figure 3.6a). We quantified total numbers of 
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tdTomato-positive cells during development and found that approximately 70.1% ± 5.054 
(n = 4 rats) cells labeled were positive for tdTomato at P9, compared to 33.0 % ± 7.110 at 
P35 (n = 4 rats) and 29.11% ± 5.300 (n = 4 rats) at P60 (Figure 3.6a), indicating that the 
majority of Cre-mediated recombination events occur between the ages P9 and P35. 
Synapsin I is a developmentally regulated gene whose product, the Synapsin I 
protein, is tightly linked with synaptogenesis and maturation of synapses during the first 
postnatal weeks (Cesca, Baldelli, Valtorta, & Benfenati, 2010; Hoesche et al., 1993). We 
examined total postnatal Synapsin I protein levels in the wildtype rat hippocampus at 
several postnatal time-points by immunoblot using an antibody against Synapsin I. At P9, 
Synapsin I levels were low (1.554 ± 0.06 Optical Density (OD), approximately 70% of 
adult levels, Figure 3.6e) and rapidly reached adult levels by P20 (2.19 ± .1202 OD; p = 
0.0033), then remained stable throughout the P35 (2.102 OD ± 0.1247) and P60 (2.206 
OD ± 0.1266) time points. These results are consistent with studies that examined 
Synapsin I expression in the rat cortex (Pinto, Jones, & Murphy, 2013) and mouse 
hippocampus, as well as the rat Synapsin I promoter expression in mouse brain (Hoesche 
et al., 1993) during development. Taken together, these data indicate that Cre-mediated 
recombination of tdTomato and subsequent expression of Cerulean in NASTIE is linked 
to the developmental profile of Synapsin I expression. Furthermore, it indicates that 
developmental regulation of Synapsin I during early life has important consequences on 






Monitoring spontaneous and evoked calcium dynamics in NASTIE 
labeled hippocampal astrocytes and neurons 
We next determined whether NASTIE would drive GECI expression sufficient for 
calcium signaling studies. Astrocytes play a prominent role in the modulation of synapses 
and synaptic transmission but experimental approaches for studying their activity have 
been very limited until recently. Genetically encoded calcium indicators such as 
GCaMP6 have proven to be useful for imaging studies of astrocyte activity. Astrocytes, 
in vivo and in brain slices, display frequent spontaneous astrocyte calcium events, 
particularly in the fine processes. We recorded astrocyte calcium signals in acute brain 
slices of the hippocampus prepared from NASTIE transfected rats. Astrocytes were 
identified by their characteristic morphology and the expression of tdTomato throughout 
in cell bodies and processes (Figure 3.7a, b). We observed large amplitude spontaneous 
localized calcium transients throughout astrocyte processes but very infrequent somatic 
events, as previously reported by our group and others (Gee et al., 2015). Frequent 
calcium transients were also observed in small compartments in astrocyte microdomains 
(Figure 3.7c).  
Next, we validated the GCaMP6f response in individual neurons. Neurons in 
acute brain slices show little spontaneous activity, so we investigated direct activation of 
neurons by focal application of kainate to acute brain slices prepared from NASTIE rats. 
Fig. 3.7l-p shows an example of the change in GCaMP fluorescence observed upon 
application of a 20 ms puff of 500 μM kainate. Upon application of the agonist, a robust 
increase in calcium was observed (Fig 3.7q). In seven neurons, there was an average 
increase in fluorescence 258.34 ΔF/F0 ± 24.3 in response to application of kainate (7 
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brain slices; from 3 animals). Cerulean fluorescence remained stable throughout the 
recordings with minimal photobleaching. 
 
Spontaneous calcium activity differs between tdTomato and 
Cerulean positive astrocytes 
Our data indicated a subpopulation of NASTIE astrocytes in the mature rat 
expressed Cerulean, indicating they had undergone Synapsin I-dependent Cre-mediated 
recombination. We were surprised by this observation, as numerous studies have used the 
Synapsin I promoter in order to achieve strong panneuronal selective expression in the 
brain27. However, astrocytes within the brain display a range of morphologies, markers, 
and functional specializations (Oberheim, Goldman, & Nedergaard, 2012; Y. Zhang & 
Barres, 2010), and our results suggest that NASTIE detected a novel population of 
astrocytes that express Synapsin I at some point during development. To further 
investigate these potentially distinct populations of tdTomato-positive and Cerulean-
positive astrocytes, we evaluated spontaneous calcium transients in astrocyte processes.  
Cerulean-positive cells that strongly resembled astrocytes were also observed in 
acute brain slices prepared for 2-photon imaging from mature NASTIE rats (Figure 3.8a-
f). These Cerulean-positive astrocytes exhibited typical features of astrocytes, and were 
morphologically distinct from Cerulean-positive neurons (arrow in Fig. 3.8f). Frequent 
spontaneous calcium events were detected in both tdTomato-positive astrocytes and 
Cerulean-positive astrocytes, throughout the entire astrocyte syncytium. There were no 
differences detected in interevent interval (IEI), indicative of event frequency (Figure 
3.8g). The average amplitude (ΔF/F0) of events was similar between tdTomato-positive 
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astrocytes (66.86 ΔF/F0 ± 46.82 SD; a total of 3760 events in 557 ROIs from 10 cells, 7 
slices, 6 rats) and Cerulean-positive astrocytes (55.89 ΔF/F0 ± 29.16 SD; a total of 3123 
events in 543 ROIs from 9 cells, 7 slices, 6 animals) but the distribution of events showed 
separation in the ocurrence of larger ΔF/F0 events, indicating that Cerulean-positive 
astrocytes were more likely to have events that were larger in amplitude (Figure 3.8h; p = 
1.0330e-17, KS-test). Event duration of tdTomato-positive (15.05 seconds ± 13.012 SD; 
3760 events in 557 ROIs from 12 cells, 8 slices, 6 rats) and Cerulean-positive (14.83 
seconds ± 12.9 SD; 3123 events in 543 ROIs; 11 cells, 9 slices, 6 rats) astrocytes was also 
measured (Figure 3.8i). Comparison of the distribution of event duration between the two 
groups indicated that there was no separation in the traces or significant differences 
(Figure 3.8i; p = .015, KS-test).  
 
Discussion 
The goal of this study was to develop a novel tool, NASTIE, capable of 
distinguishing between astrocytes and neurons, while allowing us to monitor cell-cell 
interactions using GCaMP to study calcium signaling in both cell types. Significant 
advances in tools in the last decade, specifically the development and subsequent 
improvements upon GECIs, have provided new opportunities for understanding both 
neuron and astrocyte contributions to brain circuitry. The close proximity and complex 
interactions between these two cell types have made it clear that a complete 
understanding of brain circuit function relies on the ability to monitor and differentiate 
activity in both cell types. The NASTIE transgene was designed to allow for the 
monitoring of calcium transients in the fine processes of all transfected cells with Lck-
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GCaMP6f, while also providing a fluorescent reporter system for labeling astrocytes with 
tdTomato and neurons with Cerulean. 
The NASTIE transgene is 12,426 base pairs and is flanked by terminal repeat 
sequences recognized by the piggyBac transposase. The hyperactive piggyBac 
transposase was beneficial in achieving substantially higher integration of NASTIE in the 
rat hippocampus than wildtype piggyBac transposase. The large transgene underscores 
the utility of IUE, when compared to viral vehicles, to deliver increasingly sophisticated 
genetic tools such as NASTIE, as the relatively limited carrying capacity of most viral 
vectors disqualifies viral delivery methods for plasmids of this size with complex strong 
promoters that rely on introns (Hirsch, Agbandje-McKenna, & Samulski, 2010). 
Furthermore, the modular design of NASTIE makes it highly customizable. By swapping 
GCaMP6f for any of the growing number of number of optogenetic sensors, such as 
opsins (F. Zhang et al., 2010), iGluSnFR (Marvin et al., 2013), or rCaMP (Wu et al., 
2014), to name a few, NASTIE could be used to monitor a variety of cellular functions. In 
addition, by replacing either the CAG or Synapsin I promoter, any two specific 
populations of cells could be targeted in order to genetically distinguish cells during 
experiments in real time. 
The NASTIE transgene was designed to specifically label neurons with Cerulean 
and astrocytes with tdTomato, because the established dogma held that only neurons 
express the protein Synapsin. In these experiments, NASTIE identified a subpopulation, 
of up to 25% in mature rats, of cells that expressed Cerulean, labeled positive for the 
astrocyte-specific marker GFAP, and also displayed many morphological and functional 
characteristics of astrocytes. We were somewhat surprised by this observation since 
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Synapsin I has been reported to be a neuron-specific protein (Huttner, Schiebler, 
Greengard, & De Camilli, 1983), although expression has been shown in the testes 
(Harno, Cottrell, & White, 2013). Furthermore, expression of the rat Synapsin I promoter 
with viruses was reported to be restricted to neuronal cells (Dittgen et al., 2004; Jackson, 
Dayton, Deverman, & Klein, 2016). Cerulean-positive astrocytes might be explained by a 
number of possible scenarios such as a) “leaky” expression of the Cerulean gene, (i.e., 
expression of Cerulean occurred in cells that did not undergo recombination), b) or by 
nonspecific expression of the Cre gene (i.e., expression not under the control of the 
Synapsin I promoter), or c) expression of Synapsin in a subset of astrocytes.  It is unlikely 
that “leaky” Cerulean expression is responsible for Cerulean+ astrocytes, because in a 
control experiment in MEF cell lines that were transfected with either the complete 
NASTIE transgene or a the immediate predecessor plasmid, lacking Synapsin-Cre, only 
tdTomato gene expression occurred until Cre was provided exogenously. In addition, we 
believe that nonspecific Cre expression is unlikely to account for Cerulean+ astrocytes, 
given that the temporal pattern of Cerulean expression corresponds to the developmental 
regulation of Synapsin I expression in the hippocampus, with more astrocytes expressing 
Cerulean at the later developmental time points. Furthermore, chromosomal integration 
site-mediated missexpression of Cerulean is unlikely because Cerulean expressing 
astrocytes were seen in multiple independent electroporated rats. It is extremely unlikely 
that the random integration of NASTIE in to the chromosome identified multiple sites in 
the genome that yield the same misexpression pattern. Indeed, the presence of Cerulean+ 
astrocytes suggests that this population reflects a genetically distinct population of 
astrocytes that expresses Synapsin I at some point during their lineage and therefore may 
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have a distinct function associated with this expression pattern. 
Cellular heterogeneity of astrocytes is a topic that has received little direct 
attention until very recently. There is a growing recognition of an expansive 
heterogeneity among astrocytes, including the existence of specific astrocyte 
subpopulations with differential molecular and functional properties (Farmer et al., 2016; 
Lin et al., 2017). That these subpopulations are determined, in part by neuronal-astrocyte 
signaling during development, suggests that a modular plasmid such as NASTIE, would 
be beneficial for this line of study. The study of diverse astrocyte subpopulations 
represents a potential new way of thinking about brain circuit function and with it, will 
come the need for new tools.  Spontaneous calcium-induced fluorescent transients are a 
prevalent feature of astrocytes and are proposed to be an important factor in intracellular 
signaling. While the role of spontaneous astrocytic calcium activity is not well 
understood, it seems likely to serve as a mechanism of intracellular signaling. While 
some small difference was seen, our initial analysis did not identify spontaneous 
transients as a distinguishing factor between tdTomato-positive and Cerulean-positive 
astrocytes. However, investigation of spontaneous calcium activity with GECIs has 
illuminated the diversity of signals exhibited within territories of single astrocytes. 
Therefore, while we are currently exploring, in greater depth, the study of spontaneous 
calcium activity in astrocytic-neuronal networks, the data gathered here clearly 
demonstrate the kind of information that can be gathered using NASTIE to label multiple 
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Figure 3.1. A schematic diagram of the Neuron Astrocyte Specified Transgene with in utero Electroporation, NASTIE, 
transgene and Cre-recombinant product. 
This 12,462 base pair transposable transgene enables Cre-mediated recombination through rat synapsin I promoter driven Cre 
that restricts expression to cells expressing Synapsin, NASTIE differentiates Synapsin I expressing cells from other transfected 
cells, through the expression of Cerulean. Cerulean is expressed as a consequence of the Cre-mediated recombination of 
tdTomato. All transfected cells express the calcium indicator, GCAMP6f. The NASTIE transgene is flanked by two piggyBac 
terminal inverted repeats (TIR) that are recognized by the piggyBac transposase (encoded on a second cotransfected plasmid, 
not shown) that mediates the insertion of the transgene into a chromosome. 
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Figure 3.2. Comparison of NASTIE expression with hyperactive and wildtype 
piggyBac transposase. 
NASTIE was colectroporated with the same concentration of either wildtype transposase 
(WT PBase) or hyperactive transposase (hyperPBase). (a) Example 20x images of 
transfected rat hippocampus demonstrates higher number of cells expressed either 
tdTomato or Cerulean at P9 with WT compared to Hyperactive transposase. (b) 
Quantification of number of cells labeled with hyperactivePBase (grey, square) vs WT 
pbase (black, circle) demonstrates a two-fold increase in the overall number of cells 




































Figure 3.3. Validation of NASTIE transgene expression and function in cell culture. 
A human neuroblastoma cell line, SH-SY5Y (a-c) and primary dissociated neuronal 
cultures (d-f) were used to validate expression of NASTIE transgenes. Transfected SH-
SY5Y cells demonstrate functional expression of TdTomato, Cerulean, and GCaMP 
genes. Fluorescence is contained in the boundaries of cells. Primary neurons transfected 
with NASTIE exhibited GFP and Cerulean (d) fluorescence and exhibited spontaneous 
epileptiform bursting behavior. (e-f). Representative individual traces of GCaMP6f 
fluorescence changes (ΔF/F0) of bursting behavior (g). The color-coding of the traces 








Figure 3.4. Close apposition of astrocyte and neuron processes in acute brain slices. 
High magnification 2Photon images of NASTIE labeled neuronal processes (blue) and 
astrocyte (red) in the stratum radiatum of hippocampus in acute brain slice. (a-f) NASTIE 













Figure 3.5. Characterization of cell-types labeled by NASTIE throughout 
development. 
Representative images of (a) GFAP and tdTomato positive cells; (b) Cerulean and NeuN 
positive; (c) and Cerulean and GFAP positive cells in P60 animals. Quantification of 
tdTomato- and Cerulean-positive cells that colabeled with NeuN (neuronal marker) and 
GFAP (astrocyte marker). The total percentage of tdTomato or Cerulean cells that labeled 























































Figure 3.6. Cre-mediated recombination of NASTIE mimics endogenous Synapsin I protein expression. 
(a-b) Representative images of the CA1 region from postnatal age P9 and P35 rat hippocampi transfected with NASTIE. (c) 
Quantification of labeled cells demonstrates that at P9, the majority of NASTIE transfected cells are tdTomato-positive. By 
P35, however, the majority of cells are Cerulean. *** = p < .001 (d) Western Blot of endogenous Synapsin I expression in P9, 
P20, P35, and P60 WT rat hippocampus. (e) Quantification of the relative density of bands compared to control (B-actin) over 
time demonstrates that synapsin levels are initially low and rise rapidly between P9-P20 to reach adult levels. ** = p <. 01




























































Figure 3.7. Spontaneous and evoked calcium transients are observed in NASTIE 
astrocytes and neurons in acute brain slices. 
Mean calcium activity projection image of an astrocyte expressing tdTomato (a), Lck-
GCaMP6f (b), and overlay (c) in an acute brain slice. (d-h), frames from a movie 
demonstrating spontaneous calcium transients throughout the astrocyte, including activity 
in distinct microdomains, as indicated arrows. Example mean calcium activity projection 
of a neuron expressing Cerulean (i), GCaMP (j), and overlay (k). (l-p) Time series of 
intracellular neuronal calcium increases induced by focal application of kainate (500 uM) 
from a glass pipette (white dotted line) in an acute brain slice prepared from NASTIE rat. 
The pseudocolor scale displays changes in relative Lck-GCaMP6f emission. (q) 
Representative individual traces of GCaMP6f fluorescence changes (ΔF/F0) in response 

































Figure 3.8. Spontaneous astrocyte calcium activity varies between tdTomato-
positive and Cerulean-positive astrocytes. 
Example images of NASTIE transfected Cerulean-positive and tdTomato-positive 
astrocytes in brain slices prepared from mature rats show complete expression of either 
Cerulean or tdTomato . Panels a-f show example images of Cerulean-positive astrocyte 
and neuron from a mature NASTIE rat. Cumulative histograms displaying spontaneous 
event amplitude (g), Interevent Interval (h), Amplitude (i), Event Duration are shown. 
TdTomato-positive astrocyte frequencies are shown in red and Cerulean-positive 
astrocyte frequencies are in blue. The calculated p-value from a Kolmogorov-Smirnov 
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CALCIUM SIGNALING IN REACTIVE ASTROCYTES IN A MODEL OF 
TEMPORAL LOBE EPILEPSY  
Abstract 
The importance of astrocytes in almost all aspects of brain physiology is now 
widely recognized. The processes of astrocytes are closely apposed to neuronal synapses, 
and astrocytes can modulate neuronal activity by regulating extracellular potassium and 
glutamate. Furthermore, astrocytes may directly affect the excitability of neurons through 
the release of signaling molecules such as glutamate and ATP. Temporal lobe epilepsy is 
a disorder that has historically been understood through a “neurocentric” lens with a 
focus on how neural circuit dysfunction leads to hyperexcitability and seizures. Reactive 
astrocytes in epileptic and epileptogenic tissue also show dramatic changes in 
morphology and protein expression, but their functional properties remain poorly 
understood.   
In the kainic acid-induced status epilepticus model of temporal lobe epilepsy, 
astrocytes in the hippocampus become reactive shortly after status epilepticus and before 
the onset of spontaneous seizures, during a window referred to as the latent period. 
Recently, our laboratory found that reactive astrocytes during the latent period begin to 
express kainate receptor subunits and this expression persists through the development of 
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chronic epilepsy. The function of kainate receptors on reactive astrocytes, however, is 
currently unknown.  The experiments in this chapter were designed to answer two 
questions: 1. What are the properties of spontaneous calcium signals in reactive 
astrocytes during the latent period? 2. Are the kainate receptors that are expressed on 
reactive astrocytes functional? To answer these questions, the genetically encoded 
calcium indicator, Lck-GCaMP6f, was expressed in the rat brain. Reactive astrocytes 
imaged in acute brain slices obtained from rats experiencing status epileptics (SE) 
showed longer interevent intervals and duration of spontaneous calcium events compared 
to saline-treated controls. In addition, astrocytes exhibited a bimodal response to 
application of the kainate receptor agonist, (RS)-2-amino-3-(3-hydroxy-5-tert-
butylisoxazol-4-yl) propanoic acid  (ATPA), suggesting that there are two populations of 
reactive astrocytes, those that express functional kainate receptors and those that do not. 
Taken together, these results identify changes that occur in calcium signaling in reactive 
astrocytes during the process of epileptogenesis and may thus provide new targets for 
disease modifying therapies.  
 
Introduction 
Astrocytes occupy a strategic position in the brain where they can act as an 
intermediary between neurons, blood vessels, and the cerebral spinal fluid (CSF).  This 
location is ideal for sensing and responding to overall changes in brain state. Much 
consideration has focused on the role of intracellular Ca2+ signaling in the physiology and 
function of astrocytes in a variety of contexts throughout the brain. Work over the past 
two decades has led to a revolution in the way that astrocytes are understood in the 
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context of brain physiology. In light of this, it is perhaps unsurprising that recent studies 
have also begun to elucidate their involvement in the etiology in a host of neurological 
disorders, including temporal lobe epilepsy (TLE) (Coulter & Steinhauser, 2015; 
Steinhauser & Boison, 2012; Wetherington, Serrano, & Dingledine, 2008).  
 
Astrocytes become reactive in response to CNS injury 
In response to injury, healthy astrocytes undergo a multistage, defensive reaction 
and transform into a reactive state, commonly referred to as reactive astrogliosis (Burda 
& Sofroniew, 2014). Astrocyte reactivity involves a host of morphological, 
transcriptional, and functional changes. Of these changes, the most commonly recognized 
characteristic of reactive astrocytes is high levels of expression of the intermediate 
filament Glial Fibrillary Acidic Protein (GFAP) (Clarke, Shetty, Bradley, & Turner, 
1994). Increases in GFAP expression, and in the number and length of GFAP-positive 
processes, is a characteristic trait of reactive astrocytes, and as such, 
immunohistochemical detection of increased expression of GFAP is used as standard and 
reliable marker of reactive astrocytes throughout the CNS and spinal cord (Faulkner et 
al., 2004; Oberheim, Goldman, & Nedergaard, 2012; Zamanian et al., 2012).  
The extent of reactive astrogliosis is often graded, depending on the type and 
severity of the insult, and can range in intensity from a mild, to severe phenotype called a 
glial scar (Burda & Sofroniew, 2014; Sofroniew & Vinters, 2010). Astrocytes express 
many transmembrane receptors and can detect and respond to signals in the extracellular 
space that reflect changes in overall brain homeostasis. Reactive gliosis is regulated by a 
large array of extracellular signals, which are largely dependent on the type of triggering 
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CNS insults. The molecular signals causing reactive astrogliosis can be traced back to all 
cell types found in the CNS, including neurons, microglia, oligodendrocytes, pericytes, 
endothelial cells, and other astrocytes (Burda & Sofroniew, 2014). Many different types 
of intercellular signaling molecules are able to trigger reactive astrogliosis, including 
growth factors and cytokines, immune mediators such as lipopolysaccharide and other 
Toll-like receptor ligands, neurotransmitters, purines such as ATP, reactive oxygen 
species (ROS), hypoxia and glucose deprivation, proteins associated with 
neurodegeneration such as β-amyloid, molecules associated with metabolic toxicity such 
as NH4+, and regulators of cell proliferation (Ben Haim, Carrillo-de Sauvage, Ceyzeriat, 
& Escartin, 2015; Sofroniew, 2009; Sofroniew & Vinters, 2010). 
 These extracellular signals act on numerous receptors at the astrocyte membrane 
to trigger a host of intracellular signaling cascades causing large-scale transcriptional 
changes (Ben Haim et al., 2015). These signaling cascades seem to converge on the Janus 
Kinase/Signal Transducer and Activator of Transcription (JAK/STAT) pathway 
(Ceyzeriat, Abjean, Carrillo-de Sauvage, Ben Haim, & Escartin, 2016; Pekny & Pekna, 
2014). Pharmacological inhibition of the JAK/STAT pathway in a mouse model of 
Parkinson’s disease decreases GFAP expression, suggesting that the JAK/STAT3 
pathway is required to induce astrocyte reactivity. Furthermore, other cascades including 
the Nuclear Factor of Kappa light polypeptide gene enhancer in B-cells (NF-κB) 
pathway, the calcineurin (CN) pathways, and the Mitogen-Activated Protein Kinase 
(MAPK) pathway (Ben Haim et al., 2015) are involved in regulating and maintaining 
astrocytes in a state of reactivity. Furthermore, many additional levels of complexity 
potentially exist due to cross talk between these intracellular signaling pathways, as well 
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as posttranscriptional regulation in gene expresses due to changes in microRNAs (Ben 
Haim et al., 2015; Iyer et al., 2012).  
The causal relationship and contributions of reactive astrocytes to disease 
progression is unclear (Sofroniew, 2005). The effects of reactive gliosis can be viewed as 
beneficial or detrimental, depending on experimental procedure, disease model, and 
extent or stage of astrogliosis (Ben Haim et al., 2015). Two recent key studies provide 
compelling evidence that reactive astrocytes cause hyperexcitability in brain networks. 
The first study used high titers of adeno-associated virus (AAV) to induce astrogliosis 
throughout the hippocampus (Ortinski et al., 2010). This led to downregulation of the 
astrocytic enzyme glutamine synthetase, disrupting hippocampal inhibition, and leading 
to widespread neuronal hyperexcitability in acute brain slices. In addition, Robel et al. 
(2015) developed a mouse model of reactive astrogliosis by chronically deleting β1-
integrin in GFAP-expressing cells (Robel et al., 2015). β1-integrin knockout mice had 
spontaneous, recurrent, generalized tonic–clonic seizures in vivo and the astrocytes 
showed a number of impairments, including alterations in potassium and glutamate 
buffering. Taken together, these two studies provide evidence to suggest that reactive 
astrogliosis leads to hyperexcitability and seizures. 
 
Human mesial temporal lobe epilepsy 
Temporal lobe epilepsy (TLE) is the most common form of medically intractable 
epilepsy and is defined by seizures that originate from the temporal lobe. A common 
pathological finding in patients with TLE is the presence of hippocampal sclerosis. It is 
found in approximately 50%-75% of temporal lobe resections and is characterized by 
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neuronal cell loss in the CA1 and CA3 cell fields, dentate gyrus, and entorhinal cortex, 
tissue shrinkage, and marked reactive gliosis throughout the hippocampus (Al Sufiani & 
Ang, 2012; Janigro, 2008; Thom et al., 2009). In a study of surgically resected sclerotic 
hippocampal tissue from TLE patients, GFAP immunoreactivity and inflammatory 
mediators (COX-2, TGF-β, NFkB) were present in astrocytes, suggesting widespread 
changes in reactive astrocytes in the sclerotic hippocampus (Das et al., 2012). 
A long-standing and fundamental question in epilepsy research is whether damage 
causes hippocampal sclerosis, and this in turn is responsible for seizures, or whether there 
is a preexisting pathology, or underlying genetic factors, which predisposes to seizures 
and later on hippocampal sclerosis. The data available suggest that among TLE patients 
undergoing surgical resection of the temporal lobe for uncontrolled seizures, precipitating 
injuries early in life are highly associated with hippocampal sclerosis. Precipitating 
injuries include febrile seizures, head trauma, birth injuries or status epilepticus (defined 
as a seizure causing loss of consciousness lasting longer than 30 minutes) (Mathern, 
Babb, Vickrey, Melendez, & Pretorius, 1995).  Thus, a common clinical manifestation of 
TLE in humans is a precipitating injury that is followed by a variable latent period, and 
eventually the development of spontaneous motor seizures.  
The current treatment for epilepsy is based on the suppression of symptoms (i.e., 
seizures) by antiseizure drugs. There are currently no therapies to modify the disease 
process in patients with a known increased risk of epilepsy due to a history of 
precipitating injury (Terrone, Pauletti, Pascente, & Vezzani, 2016). The 
term epileptogenesis encompasses the cascade of molecular and cellular events that take 
place causing a healthy brain to develops spontaneous seizures (Curia et al., 2014; 
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Pitkanen et al., 2007). The development of treatments to prevent epileptogenesis is a 
major objective in epilepsy research. However, exploring these processes in human 
tissues is limited. Often, human tissue that is available for study comes from surgical 
resection of hippocampal tissue, and thus reflects an advanced stage of epilepsy as well 
as years of exposure to antiseizure drugs. Animal models of TLE, discussed in the next 
section, provide the opportunity for careful study of this period. 
 
Animal models of TLE 
In order to better understand the pathophysiology of TLE, and to carefully study 
the mechanisms of epileptogenesis, several in vivo animal models that present features 
similar to human TLE have been developed. There are several TLE models available, and 
all recapitulate the clinical manifestations of TLE in humans, including a precipitating 
injury that is followed by a latent period with the subsequent development of spontaneous 
motor seizures. The systemic low-dose kainic acid model of TLE in rat uses the systemic 
administration of the glutamate receptor agonist kainic acid (KA) to induce status 
epilepticus (SE), defined as a period of seizure activity lasting for at least 30 minutes 
during which full consciousness does not recover (Hellier, Patrylo, Buckmaster, & 
Dudek, 1998; Williams et al., 2009). Following SE, there are no clinical signs of seizure 
activity, but significant alterations in neuronal and glial cell structure and function can 
occur. Axon sprouting, structural changes in pre- and postsynaptic receptors, changes in 
voltage-gated ion channels, alterations of homeostatic mechanisms, and neuronal 
degeneration have all been associated with epileptogenesis (Dudek & Staley, 2012). The 
duration of the latent period typically spans between 10 and 30 days after the initial SE in 
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rats, but can last as long as several months (Williams et al., 2009). Approximately 96% 
animals that have SE in the low-dose systemic KA model will go on to develop 
spontaneous recurrent seizures (Thomson, Modi, Glauser, Rausch, & Steve White, 2017). 
As mentioned previously, in human TLE and in the KA-treated rat model of TLE, 
reactive astrocytes are observed throughout the hippocampus. Data acquired from the KA 
model of TLE demonstrate that following KA-induced SE, there are dramatic increases in 
GFAP expression 7 days following SE and the increased expression of GFAP persists in 
astrocytes throughout the development of chronic epilepsy (8 weeks) (Figure 1.1A). In 
addition, reactive astrocytes following SE exhibit numerous changes in potassium 
buffering, and gene expression, including transmembrane receptor expression. These 
changes are summarized in Chapter 1. In the next section, we will discuss an aspect of 
astrocyte biology, Ca2+ signaling, that has only recently begun to be explored in TLE. 
 
Astrocyte signaling 
Astrocytes, while not electrically excitable, show a type of chemical excitation in 
the form of increases in intracellular calcium (Agulhon et al., 2008; Bazargani & Attwell, 
2016). Astrocytes express numerous G-coupled protein receptors (GPCRs) receptors 
coupled to second messenger systems, and have been shown to mobilize calcium from 
intracellular stores in response to several neurotransmitters, such as glutamate, ATP, 
GABA, adenosine, and norepinephrine (Agulhon et al., 2008; Bekar, He, & Nedergaard, 
2008).  The most widely accepted mechanism for astrocytic Ca2+ increases is via the 
canonical phospholipase C (PLC)/inositol (1,4,5)-trisphosphate (IP3) pathway. Upon 
activation of GPCR, PLC hydrolyzes the membrane lipid phosphatidylinositol 4,5-
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bisphosphate to generate diacylglycerol (DAG) and IP3, leading to IP3 receptor (IP3R) 
activation and Ca2+ release from the endoplasmic reticulum (ER) (Fiacco & McCarthy, 
2006).  Calcium elevations can be increased throughout the entire cell including the 
soma, or be localized to a few processes or astrocyte endfeet, or small, physiologically 
restricted volumes dubbed microdomains (Mulligan & MacVicar, 2004; Volterra, 
Liaudet, & Savtchouk, 2014). A recent study showed that including norepinephrine, ATP, 
or the mGluR-agonist in the extracellular solution caused unique patterns of microdomain 
activity, suggesting that microdomains are physiologically distinct, contain different 
receptors, and can experience different modes of Ca2+ increases (Agarwal et al., 2017).  
Furthermore, astrocytes in the hippocampus, cortex, and thalamus have been 
shown to exhibit intrinsic oscillations independent of neuronal activity (Aguado, 
Espinosa-Parrilla, Carmona, & Soriano, 2002; Nett, Oloff, & McCarthy, 2002; Parri & 
Crunelli, 2003; Rungta et al., 2016). When neuronal action-potential-mediated and 
spontaneous synaptic vesicle release is blocked by both TTX and bafilomycin, astrocytes 
still exhibit transient increases in intracellular calcium, particularly in the fine distal 
processes (Aguado et al., 2002; Nett et al., 2002; Parri & Crunelli, 2003). Subsequent 
experiments demonstrated that the spontaneous Ca2+ dynamics observed in astrocytes in 
vivo are similar to those described in acute slice preparations (Hirase, Qian, Bartho, & 
Buzsaki, 2004; Nimmerjahn, Kirchhoff, Kerr, & Helmchen, 2004; Wang et al., 2006).  
When the IP3R2 gene is deleted, spontaneous calcium transients are reduced in the soma 
but are still present in the fine processes (Haustein et al., 2014). This suggests that many 
signaling pathways are involved in generating spontaneous transients. To this end, a 
recent report showed that spontaneous Ca2+ signals in the fine processes depend on 
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transmembrane Ca2+influx. When Ca2+ is removed from the external solution, 
Ca2+ transients were reversibly eliminated, suggesting some unidentified Ca2+ influx 
pathway is responsible for transients in fine processes (Rungta et al., 2016).  
The observation of intracellular Ca2+ activity has led many to wonder whether 
pathological neuron-astrocyte signaling could promote abnormal neuronal 
synchronization in epilepsy (Carmignoto & Haydon, 2012; Wetherington et al., 2008). 
However, calcium dynamics in reactive astrocytes in a model of TLE have only been 
investigated in one study to date (Ding et al., 2007). This study was performed using the 
bulk-loaded calcium indicator Fluor4. Fluor4 and other synthetic dyes do not diffuse 
throughout the entire astrocytes, and tend to be restricted to the soma and major branches, 
making it difficult to accurately record calcium fluctuations throughout the entire 
astrocyte, including the fine processes (Reeves, Shigetomi, & Khakh, 2011). Since the 
publication of Ding et al. (2007), the development of genetically encoded Ca2+ indicating 
proteins (GECIs) has enabled improved monitoring of astrocyte Ca2+ dynamics 
throughout astrocyte fine processes (Gee et al., 2015; Gee et al., 2014; Shigetomi, 
Kracun, & Khakh, 2010; Shigetomi, Patel, & Khakh, 2016). A recent study in a mouse 
model of Huntington’s disease, GECIs uncovered dramatic changes in spontaneous and 
stimulation evoked Ca2+ dynamics in striatal astrocytes (Jiang, Diaz-Castro, Looger, & 
Khakh, 2016). Changes in the frequency, duration, and amplitude of spontaneous 
astrocyte activity were observed, and these changes proceeded the appearance of 
astrogliosis in this model, prompting the authors to hypothesize that disrupted astrocyte 
engagement within the striatal circuit may drive Huntington’s disease progression. To 
date, no study has utilized GECIs to investigate changes in spontaneous astrocytes signals 
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during the latent period during TLE. Therefore, we sought to explore astrocyte signaling 
in the hippocampal circuit in saline and KA-treated rats during the latent period.  
The standard method for delivering GECIs to the rat brain has been through viral 
vectors, but this approach has a number of drawbacks (Gee et al., 2015). Viruses require 
invasive injections, often times near the location and time of imaging. Furthermore, 
adeno-associated virus, while extremely useful for delivering transgenes and relative non-
immunogenic, has a relatively small carrying capacity. To address this, we used in utero 
electroporation (IUE) to express a plasmid containing the newest GECI, Lck-GCaMP6f, 
which was optimized for imaging in astrocyte fine processes by the inclusion of the 
membrane-tethering tag, Lck (Shigetomi et al., 2010). The details of the construction and 
validation of the NASTIE plasmid are discussed in Chapter 3. We monitored intrinsic 
calcium activity in astrocyte processes in the hippocampus of adult rats that had 
previously undergone IUE and were 6-12 days postSE and compared them to saline 
treated age-matched controls. 
 
Reactive astrocytes in the latent period of epilepsy express 
kainate receptors 
Reactive astrocytes in TLE demonstrate profound changes in protein expression, 
including expression of cell surface receptors. Several reports indicate an increased 
expression of Type 1 and Type 2 metabotropic glutamate receptors (mGluRs) in 
astrocytes in both patients and animal models of TLE (Aronica et al., 2000; Ferraguti, 
Corti, Valerio, Mion, & Xuereb, 2001; Notenboom et al., 2006; Umpierre et al., 2016). 
To date, only one study has investigated the functional consequences of increased 
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expression of mGluRs following SE (Ding et al., 2007). Intriguingly, this study found 
that mGluR activation played a role in altered Ca2+ activity in astrocytes, and that 
blocking Ca2+ release was neuroprotective, suggesting that altered Ca2+ dynamics of 
astrocytes could contribute to the development of TLE. 
Interestingly, data from our laboratory utilizing immunohistochemistry and 
colocalization analysis as well as Western Blotting on glial enriched tissue fractions in 
control and KA-treated animals revealed a dramatic increase in the expression of KAR 
subunits 1 week following KA-induced SE that, for some subunits, persisted 8 weeks 
following SE, at a time when chronic epilepsy has developed (Vargas, Takahashi, 
Thomson, & Wilcox, 2013).  Kainate receptors are a class of ionotropic glutamate 
receptor comprised of “low-affinity” GluK1, 2, and 3 and “high affinity” GluK4 and 
GluK5 subunits. The GluK1, 2, and 3 subunits can form functional homomeric KARs, 
while the GluK4 andGluK5 subunits cannot. However, GluK4 and GluK5 can assemble 
with GluK1, 2, or 3 to form functional heteromeric receptors (Lerma, Paternain, 
Rodriguez-Moreno, & Lopez-Garcia, 2001). In addition to their classical ionotropic 
function, KARs can also couple to G-proteins, thus bestowing a metabotropic signaling 
mechanism onto these receptors (Lauri et al., 2003; Rozas, Paternain, & Lerma, 2003; 
Ruiz, Sachidhanandam, Utvik, Coussen, & Mulle, 2005). It is anticipated that kainate 
receptor activation will trigger Ca2+ transients in astrocytes, regardless of signaling 
mechanism, from the latent groups while having no effect in nonreactive astrocytes from 
control tissue. 
The functional significance of KAR expression in reactive astrocytes is unknown. 
The novel expression of KARs on reactive astrocytes could represent a previously 
  
96 
uncharacterized mechanism that mediates pathological neuron-glia signaling through 
activation of ionotropic and/or metabotropic KARs expressed during epileptogenesis. 
Therefore, as a first step towards determining if KARs play a role in epileptogenesis, the 
present study tests the hypothesis that KARs on reactive astrocytes are functional and that 




Male and Female Sprague-Dawley rats (Charles River Laboratories, Raleigh, NC) 
were used in this study. Animals were housed in individual cages in a temperature 
controlled room (70-74ºF) with a 12h light/12h dark cycle, and had ad libitum access to 
water for the entire study. All animal procedures were performed in accordance with the 
NIH Guide for the Care and Use of Laboratory Animals and approved by the University 
of Utah Institutional Animal Care and Use Committee. 
 
In utero electroporation 
Transfection of the embryonic rat brain was accomplished via IUE. After 
induction of a deep anesthetic state with ketamine/xylazine (80/20 mixture, i.p.), the 
abdomen of a pregnant rat was shaved and swabbed with betadine. A laparotomy was 
performed and embryos (gestational day 13.5–14.5) within the uterine horn were exposed 
and gently placed on a sterile and irrigated gauze pad. Because the embryos at this age 
stretch the uterus, they can be clearly visualized with only the aid of a bright fiber optic 
lamp. A glass capillary tube was pulled (Sutter Instrument, Novato, CA, USA) to a fine 
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point by high heat and filled with a mixture of fast green (1%; Sigma-Aldrich, St. Louis, 
MO, USA) and DNA plasmid solution (4 μg/μl final). The DNA plasmid solution 
consisted of 2 μg/μl of NASTIE and 2 μg/μl of transposase source (Figure 4.1). The 
pipette tip was inserted through the uterus into one of the lateral ventricles of the embryo 
brain and a small volume (~2–5 μl) of the mixture was pressure injected by applying 
positive pressure through a mouth pipette. Successful injection was confirmed visually by 
observing fast green filling of the ventricle. For electroporation, a pair of sterilized gold 
copper alloy plate electrodes (1 × 0.5 cm) were positioned across the head of the embryo 
on the uterus exterior, and three very brief (1 ms) voltage pulses (65 V) were discharged 
across the electrodes. In order to specifically target the developing hippocampus and 
cortex, the paddles were rotated across the top of the head with the positive electrode 
placed opposite the injected side, as previously described (Gee et al., 2015; Navarro-
Quiroga, Chittajallu, Gallo, & Haydar, 2007; Pacary et al., 2012). The embryos within the 
uterus were returned to the body cavity and the incision closed with sterile Ethicon silk 
suture 4.0 (Ethicon, Somerville, NJ, USA). Animals were weaned from the mother on 
P21 and males and females were housed separately until used for experiments.  
 
EEG electrode implantation 
2-month-old (~220–280 g) male and female rats that had previously undergone 
IUE were implanted with EEG electrodes as follows. After anesthetization with a mixture 
(20:80) of ketamine/xylazine, animals were placed in a stereotaxic apparatus. A bipolar 
(with ground) electrode (MS333-3- B, Plastics One, Roanoke, VA) was used for surface 
recordings (Thomson & White, 2014). Two holes were drilled on the right side of the 
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midline, and one lead was placed into each of the craniotomies to provide differential 
recordings. A third lead was placed in a third craniotomy left of the midline to be used as 
the ground electrode. Three additional holes were drilled in the surrounding space and 
screws were fashioned. The electrodes were fixed in place with dental cement, and the 
skin was sutured around the skull. 
 
Video EEG recording and monitoring of latent period 
Rats were permitted 14 days to recover from surgery before being placed into a 
video-EEG (vEEG) suite, and monitored 24/7 using vEEG for the duration of the 
experimental trial. Animals were tethered to a rotating commutator (Plastics One, 
Roanoke, VA) which in turn was connected to an EEG100C amplifier (BioPac Systems, 
Goleta, CA), which filtered signal below 1 Hz and above 100 Hz at a sampling rate of 
500 Hertz. EEG was streamed from a BioPac MP150 Recording system (BioPac Systems 
Inc., Goleta, CA), and video was captured by a pair of DVP 7020BE capture cards 
(Advantech, Milpitas, CA). Video and EEG data were synchronized and written to disk 
using custom software (Thomson & White, 2014). Video was stored in MPEG4 format, 
and EEG was stored in a custom file format. Spectrograms representing changes in 
electrographic power (1–100 Hz, 90 s window, 45 s step) during KA injections were 
plotted across a 24 hour period that included 1 hour of baseline activity used to normalize 
EEG power spectra. Postprocessing was performed in MATLAB (MathWorks, Natick, 
MA), using the Chronux Toolbox (http://chronux.org/).  
This study was concerned with changes in astrocytes following SE during the 
latent period, prior to the development of recurrent spontaneous seizures, so rats were 
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monitored continually for spontaneous seizures and eliminated from the study if 
spontaneous seizures were observed.  Video EEG monitoring was performed 24 hours 
per day until rats were sacrificed for the imaging portion of the study. Video EEG files 
were reviewed for seizures by a reviewer blinded to the treatment paradigm. Two rats, 12 
and 13 days after SE, displayed seizure activity after the initial KA-induced SE activity 
and were thus eliminated from the study (Table 4.1).  
 
Induction of status epilepticus 
After a 24 hour acclimation period in the video-EEG chambers, SE was induced 
in rats 150 – 180 g using the repeated low-dose kainic acid (KA) protocol as described 
previously (Hellier et al., 1998; Smith, Adams, Saunders, White, & Wilcox, 2007).  KA 
(Tocris Bioscience, Bristol) was dissolved for 1 hour in sterile isotonic saline prior to first 
injection. Rats received an initial 10 mg/kg injection of KA, followed by a 5 mg/kg 
injection an hour later. Animals continued to receive 5 mg/kg injections every 30 
minutes. Rats were continuously monitored for electrographic and convulsive motor 
seizures. For controls, saline (0.9%) was substituted for KA.  Injections ceased following 
the onset of the first Racine stage 4 or 5 seizure, defined as forelimb clonus with rearing 
(stage 4), possibly escalating into loss of postural control (stage 5)(Racine (1972 )). To be 
included in the study, rats had to exhibit a minimum of 3 stage 4/5 seizures over a 3-hour 
observation period. If an animal was nearing its endpoint, half-doses (2.5 mg/kg) were 
given to avoid excessive toxicity and mortality. All animals were observed for behavioral 
seizures and EEG data was captured with synchronized video recording. SE self-
terminated by 24 hours after the first KA injection. Approximately 6 hours after the first 
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injection, rats were given an injection of 0.9% saline (1 ml, subcutaneous) and access to -
Pedialyte, a sweetened beverage fortified with electrolytes, to prevent dehydration. 
Subcutaneous fluids and access to Pedialyte (Abbott Laboratories, purchased at a local 
grocery store) were continued for 2–3 days if the animals appeared dehydrated. Rats were 
allowed access to food and water ad libitum while being housed individually in a 
temperature- and light-controlled (12 h light/dark cycle) environment until 
experimentation. 
 
Acute brain slice preparation 
 Rats previously administered KA, as well as vehicle treated control rats, were 
monitored using video EEG as described above to ensure the absence of spontaneous 
seizures and confirm that the rodents were still in the latent period of TLE disease 
progression. Acute brain slices were prepared from rats 6-13 days following KA-induced 
SE, or from saline-injected controls, in a manner similar to previously described methods 
(Otto, Yang, Frankel, White, & Wilcox, 2006; West, Dalpe-Charron, & Wilcox, 2007). 
Rats were deeply anesthetized with isofluorane and brains were rapidly dissected and 
placed in ice-cold (4 ºC) oxygenated sucrose Ringer’s solution (95% O2/5% CO2) 
containing (in mM): 200 sucrose, 26 NaHCO3, 10 D-glucose, 3 KCl, 3 MgSO4, 1 CaCl2, 
and 1.4 NaH2PO4. The pH was maintained at 7.4 by saturation with 95% O2-5% CO2. 
Brains were then trimmed, cut down the midline, and one hemisphere was glued dorsal 
side down to the mounting disk of a Vibratome tissue slicer (Vibratome, St. Louis, MO).  
Coronal brain slices (400 µm) containing both the medial entorhinal cortex and 
hippocampus were cut in oxygenated sucrose Ringer’s solution (4 ºC).  Following 
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sectioning, slices were transferred to a holding chamber filled with oxygenated artificial 
cerebrospinal fluid (ACSF; room temperature) containing in mM:  126 NaCl, 26 
NaHCO2, 10 D-glucose, 3 KCl, 2 MgSO2, 2 CaCl and 1.4 NaH2PO4 and containing 10 
μM TTX for at least 1 hour.  
 
2-photon imaging 
Before imaging, slices were transferred to a heated submersion recording chamber 
(Warner Instruments, Hamden, CT, USA) and perfused with oxygenated ACSF 
containing 10 μM TTX at a rate of ~1.0 ml/min and a temperature between 29o and 30o C.  
Slices were evaluated for tdTomato-transfected astrocytes in the hippocampus using 
epifluorescence. Two-photon imaging was performed using a Prairie Technologies 
Ultima Multi-Photon Microscopy System (Bruker, Billerica, MA, USA) built around a 
SpectraPhysics Mai Tai laser source with a wavelength adjustable from 690-1040 nm 
(SpectraPhysics, Newport CA). GCaMP6f and tdTomato imaging was done with a laser 
emission wavelength of 950 nm (Akerboom et al., 2012; Drobizhev, Makarov, Tillo, 
Hughes, & Rebane, 2011). Laser scanning was accomplished using X-Y galvanometer-
mounted mirrors. Emitted photons were bandpass filtered at 490-560 for GCaMP6f and 
570-620 nm for tdTomato. Full field of view images (512 x 512) were acquired with an 
X-Y raster scan at depths spanning 20-100 μm below the edge of the slice to avoid the 
“dead zone” resulting from brain slice preparation. A water immersion 20 × 0.95 NA 
objective (Olympus, Tokyo, Japan) was used. PrairieView 5.2-5.3 software was used for 




Pharmacological activation of receptors 
Synaptic transmission was suppressed, in order to reduce neuronal sources of 
glutamate, by including 1 µM TTX in the ACSF solution to block voltage gated sodium 
channels. 500 μM each of ATPA and ATP were dissolved in ACSF and an Alexa Fluor 
Dye 568 was included in the solution. A glass electrode was pulled from borosilicate 
glass capillaries (Schott #8250 glass, World Precision Instruments, Sarasota, FL) to ~10 
μM using a micropipette electrode puller (P-97, Sutter Instruments, Novato, CA). The 
pipette was placed ~100 microns or less away from a cell of interest using a 
micromanipulator (Sensaplex, Gaithersburg, MD). Receptor agonists and ACSF were 
delivered locally by pressure application (200-500ms, ~20 psi) using picospritzer (III, 
Parker Instrumentation, Huntsville, AL) and PrairieView 5.2-5.3 Software (Bruker, 
Billerica, MA, USA) while simultaneously imaging Lck-GCaMP6f activity with the laser 
tuned to 950 nm. Movies of calcium activity were captured in a single focal plane. 
 
Image analysis 
Image analysis was accomplished using ImageJ along with Fiji: an open source 
platform for biological image processing and custom-written Matlab software that was 
developed by Roy Smeal and Tony Umpierre in the Wilcox laboratory. Example traces of 
Ca2+ activation in figures were generated by plotting the intensity of a region of interest 
(ROI) over time, after the intensity of the background ROI (F0) had been subtracted. The 
procedure for determining changes in the area of fluorescence in response to application 
of pharmacological agonists was as follows. First, .xml files containing all frames and 
metadata from movies were opened in Fiji using the BioFormats plugin. All images in the 
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GCaMP and tdTomato channels were filtered using the Hybrid 3D Median Filter plugin. 
Images from the GCaMP channel were opened in a custom written Matlab program in 
order to remove background fluorescence and reduce noise. To visualize the puff radius, 
we relied on visualization of diffusion of an Alexa Fluor 568 dye that was included in the 
pipette solution. A maximum projection of the frames containing puff diffusion was 
generated. This image was then subtracted from a single frame image just prior to the 
puff and the magic wand function in ImageJ was used to outline the puff area. The puff 
area was selected and added to the Region of Interest Manager. The “Clear Outside” 
function was used so that cells outside of the puff area were not included in subsequent 
analysis to determine changes in area of fluorescence. To determine the area of 
fluorescence of each cell before and after the puff, maximum intensity projection images 
of GCaMP activity were generated from 10 sequential frames that occurred directly 
before and after the puff was triggered. The maximum intensity projection images were 
thresholded using the IJ_IsoData algorithm in Image J. The area of fluorescence 
activation on thresholded images was measured using the “Analyze Particles” function 
within ImageJ. The change in fluorescence area was calculated as follows: 
PostPuffArea/PrePuffArea – 1 to give the change in area of fluorescence before and after 
the puff. 
 
Region of interest selection and spontaneous event detection 
In order to minimize the effect of region of interest (ROI) selection bias on our 
analysis of spontaneous calcium events, ROI selection was accomplished using 
GECIQuant from the Khahk laboratory (Srinivasan et al., 2015). Each cell had 40-60 ROI 
  
104 
(Table 4.2). Automatic time-series event detection was accomplished with custom-
written MATLAB (MathWorks, Natick, MA, USA) scripts developed by Marsa Taheri in 
the White Laboratory. ΔF/F0 time-series plots were generated for each ROI by averaging 
F values of each pixel at each time point and using the median fluorescence of all image 
frames as the baseline fluorescence (F0). The ΔF/F0 trace for each selected ROI was 
filtered with an order-3 one-dimensional median filter. The noise floor was defined as the 
median of the lower 30th percentile of fluorescence intensity values. The event threshold 
was set to three standard deviations above the noise floor with a ΔF/F0 of at least 30%. 
Using this threshold, event peaks were found with the findpeaks command in MATLAB. 
Events were eliminated if the time points adjacent to the event peak were not large 
enough (i.e., did not have a ΔF/F0 of at least 60% of the event threshold). Event durations 
were calculated as the time between the troughs before and after each event peak. The 
troughs before and after each peak were detected automatically and were defined as, 
respectively, the last or first data points before or after the peak that had a value less than 
three standard deviations above the noise floor.  
 
Statistics 
Statistical tests were performed with Graph Pad Prism 9 (GraphPad Software, La 
Jolla, CA, USA) or MATLAB Statistics Tool Box. Data are presented as mean ± SEM. 
For each set of data to be compared, we determined within GraphPad I whether the data 
were normally distributed or not. If they were normally distributed, we used parametric 
tests; otherwise, we used nonparametric tests. Paired and unpaired Student’s two-tailed t 
tests (as appropriate) and two-tailed Mann-Whitney tests were used for most statistical 
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analyses with significance declared at p < 0.05, but stated in each case with a precise p 
value. Fisher’s exact test was used to compare two groups with a binomial outcome. 
Cumulative frequency distributions were compared using Komologrov-Smirnoff (KS) 
test. When the p value was less than 0.0001, it is stated as p < 0.0001 to save space. The 
numbers of ROI’s, cells, slices, and/or rats are defined throughout on a case-by-case basis 




EEG verification of latent period 
To study the functional changes in reactive astrocytes occurring after SE and 
before the onset of spontaneous seizures acute, SE was induced in rats that had 
undergone in utero electroporation of the NASTIE plasmid using a low-dose KA injection 
protocol (Hellier et al., 1998; Smith et al., 2007; Williams et al., 2009). In the low-dose 
kainate model, the latent period is a period of low seizure probability immediately 
following the insult, which is characterized by a gradual increase in seizure probability 
that ends in the first spontaneous recurrent seizure. To verify that no seizures occurred 
following the initial SE, animals were monitored with continuous 24/7 video EEG during 
kainate injections and until sacrifice for imaging experiments. A trained individual 
blinded to treatment condition evaluated the vEEG for each animal. The entire study 
timeline is defined in Figure 4.2a. Seizures were defined by the occurrence of spikes or 
sharp wave (amplitude & >2-fold background) that lasted ~10s (Williams et al., 2009). In 
addition, electrographic seizures included an increase in EEG amplitude and a decrease in 
spike frequency as the seizure progressed. Electrographic seizures were considered 
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seizures if they occurred with a behavioral correlate such as freezing, head bobbing, face 
twitching, forearm clonus, tonic clonic seizures, etc. Two KA treated animals exhibited 
spontaneous recurrent seizures 12 and 13 days after initial SE, perhaps not unexpectedly, 
as these time points were at late end of the time frame typically thought as the latent 
period in this model, where the probability of seizure occurrence is indeed very high 
(Williams et al., 2009). These seizures were a behavioral Racine 4 and 5 and were 
accompanied by the appropriate electrographic traces. These rats were removed from the 
study (Table 4.3). EEG traces of kainite-treated, but not saline-treated, rats sometimes 
displayed interictal spiking, defined as transient electrographic events 3 x the baseline 
signal amplitude. 
Figure 4.2b shows an example control EEG spectrogram covering a 24 hour 
period including 1 hour of baseline at approximately hour -1 to 0. Saline injections begin 
at approximately hour 0. The spectrogram is similar before and after the injections with 
sporadic small increases in power in the 0-10 Hz range across the entire period. An 
example of an EEG spectrum for a kainate-injected animal is shown in Figure 4.2c. After 
KA injections, there are larger increases in power in the range of 0-25 Hz indicating the 
occurrence of seizures. An example representative seizure approximately 6 hours after 
the initial injection is shown in the insert. Of the 23 animals that were implanted with 
EEG electrodes and subjected to KA treatment, 7 (30%) did not have successful  
transfections in the hippocampus, 2 were removed from the study due to spontaneous 
seizures before sacrifice, 1 lost their EEG implant, and data from 1 rat was removed from 




Astrocytes in hippocampus of KA-treated rats exhibit thicker processes 
 
One of the hallmarks of the brain following SE is the dramatic increase in 
expression of GFAP in astrocytes. Following SE, increased GFAP expression in 
astrocytes is observed throughout the entire hippocampus including in the CA1 stratum 
radiatum (Figure 1.1). In this study, astrocytes in the stratum radiatum of the 
hippocampus in acute brain slices prepared from saline and kainate treated rats were 
identified by tdTomato fluorescence. Individual astrocytes varied considerably in shape 
and appearance, but exhibited bushy morphology with many fine processes protruding 
from the main cellular processes. Maximum projections of tdTomato revealed that 
reactive astrocytes from kainate-treated rats exhibited thicker main processes and a 
higher density of fine astrocyte processes than astrocytes from saline-treated (Figure 4.3). 
Although we did not quantify the morphological changes seen here, out observations are 
similar to those from a recent study were intracellular dye-loading was used to visualize 
the spatial domains in reactive astrocytes in the dentate gyrus following electrical 
lesioning of the entorhinal cortex. Quantification of the number of processes confirmed 
that reactive astrocytes had increases the number of primary processes leaving the soma, 
and increases in the number of processes 15 μm from the soma, but there were no 
changes in in the overall volume accessed by astrocytes (Wilhelmsson et al., 2006).  
 
Astrocyte have longer, but less frequent spontaneous calcium 
events following SE 
Astrocyte processes maintain morphologically close relationships with neuronal 
synapses. Astrocytes can detect release of neurotransmitters through calcium-dependent 
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signaling mechanisms but also show spontaneous, or intrinsic calcium elevations in the 
absence of synaptic transmission.  
In the past, synthetic calcium dyes such as Fluo-4 have been used to probe SE-
induced changes in calcium dynamics in astrocytes (Ding et al., 2007). However, these 
dyes diffuse only through the soma and major branches of astrocyte following bulk 
loading, missing important activity in the fine processes. To bypass this technical 
challenge, we employed IUE in embryonic rats to express the GECI, Lck-GCaMP6f. 
Because Lck-GCaMP6f is targeted to the membrane, we were able visualize calcium 
activity in fine processes. Rats that had undergone IUE were subsequently treated with 
either low-dose injections of KA or saline. Movies of spontaneous astrocyte activity were 
collected in the presence of 1 μM TTX to block synaptic transmission. 
Nonreactive astrocytes from healthy (control) rats demonstrated frequent 
spontaneous calcium transients throughout the entire astrocyte syncytium, in agreement 
with many other studies (Figure 4.4a) (Gee et al., 2015; Shigetomi et al., 2010; Volterra 
et al., 2014).  Most of the spontaneous calcium activity events did not propagate to the 
entire cell but were spatially restricted to small regions within the astrocytes. 
There were differences detected in the interevent interval (IEI) following SE and 
compared to slices prepared from control animals (Figure 4.4b). Reactive astrocytes had 
longer intervals between events (30.57 ± 22.99 (SD) seconds; n = 3819, from 13 cells, 11 
slices, 5 rats) than control astrocytes (42.78 ± 33.29 (SD) seconds; n = 3813 events, from 
15 cells, 12 slices, 6 rats; p < .0001; Mann Whitney), indicative of decreased frequency 
of events. Furthermore, the cumulative distribution of IEI showed considerable separation 
between spontaneous events in astrocytes imaged in the two groups (p = 5.9665 e-54, 
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Komlogrov Smirnoff (KS) test). We also observed separation in the distributions of basal 
spontaneous Ca2+ event duration of in reactive astrocytes in brain slices prepared from 
KA treated rats compared to control (p = 1.720 e-80 KS test) (Fig. 4.4b). The duration of 
calcium events was longer in reactive astrocytes (19.96 ± 20.52 (SD) seconds; 4843 
events, from 13 cells, 12 slices, 5 rats) than astrocytes from control tissue (14.41 ± 13.95 
(SD) seconds; 4476 events, from 15 cells, 12 slices, 6 rats; p < .0001; Mann Whitney). 
Furthermore, the cumulative distribution of event duration of reactive astrocytes was 
increased compared to astrocytes from saline-treated rats (p = 1.720 e-80). There were 
differences in the amplitude between control (59.46 ± 56.96 (SD) ΔF/F0; 4476 events, 
from 13 cells, 11 slices, 5 rats) and reactive astrocytes (56.14 ± 52.96 (SD) ΔF/F0; 4843 
events, from 15 cells, 12 slices, 6 rats; p = .0180; Mann Whitney)(Figure 4.4c). However, 
while the differences in the cumulative distributions were statistically significant (p = 
7.9471e-4) when compared using the KS test, we saw no separation in the traces, 
suggesting that the differences between the groups may not be biologically significant. 
 
Astrocytes from KA-treated rats respond to application of 
ATPA 
Our published data indicate that all five KAR subunits are expressed on astrocytes 
during the latent period, with the GluK1 subunit most highly expressed 7 days and 8 
weeks post SE (Vargas et al., 2013). To determine if the protein expression of KARs on 
reactive astrocytes translates to functional KARs, we imaged GCaMP6f activity in 
astrocytes during direct application of ATPA  (500 μM), a selective pharmacological 
agonist of the Gluk1 KAR subunit (Palygin, Lalo, Verkhratsky, & Pankratov, 2010). 
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Transfected astrocytes in the stratum radiatum of the hippocampus were identified based 
on the expression of tdTomato (Figure 4.2) and local application of drug solution was 
accomplished by focal pressure application with a picospritzer. The ideal location of the 
pipette tip in relation to the astrocytes being imaged, as well as the duration and pressure, 
of the picospritzer application, were determined based on astrocyte response using 500 
μM ATP, because protoplasmic astrocytes in the hippocampus are known to express 
metabatropic ATP receptors and respond to changes in the exogenous application of ATP 
with large calcium transients that are readily observable with GCaMP (Gee et al., 2014; 
Nakahata, Nabekura, & Murakoshi, 2016).  
GCaMP6f and tdTomato were simultaneously excited with a laser emission 
wavelength of 950 nm. Focal application of ACSF and ATP (500 µM) was also 
performed with simultaneous calcium imaging as negative and positive controls, 
respectively. ACSF was applied to determine any fluctuations of calcium in astrocytes 
was due to response to mechanostimulation from the direct application. Application of 
ATP was used to confirm health of the slices, as it is a well-characterized agonist that 
stimulates G-protein-coupled P2Y receptors expressed on the membrane, which results in 
the mobilization of calcium from internal stores (Pearce, Murphy, Jeremy, Morrow, & 
Dandona, 1989; Salter & Hicks, 1995). In general, healthy astrocytes returned to baseline 
calcium levels within 20-30 seconds. 
 Astrocytes from control brain slices (n = 6 cells; 4 slices, 4 animals) did not 
respond to application of 500 μM ATPA (Figure 4.5a, Saline-group, Change in area of 
fluorescence A.U. -0.062 ± .101), consistent with the observation that control astrocytes 
do not express KAR subunits (Vargas et al., 2013). Application of 500 μM ATP to 
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astrocytes in brain slices from control rats (n= 6 cells; 4 slices; 4 animals) resulted in a 
several-fold increase in ΔF/F0 above baseline, consistent with previous reports (Gee et al., 
2015). Application of ATP also resulted in an increase in the total area of fluorescence 
(Figure 4.5b, Saline-group, Change in area of fluorescence A.U. 1.38 ± 0.548). Also 
consistent with the literature, application of ACSF had very minimal effects on the area 
of GCaMP fluorescence in astrocytes from control tissue (Figure 4.5c, Saline-group, 
Change in area of fluorescence A.U. 0.10 ± 0.040). 
Applying 500 μM ATPA to astrocytes in brain slices from KA-treated animals 
revealed two distinct populations of astrocytes. One population responded to application 
of ATPA with a large increase in GCaMP fluorescence (1.56 A.U. ± 0.284; n = 6/12 
cells; 4/7 slices; 5 animals), while the other population showed relatively no changes in 
fluorescence area after  (0.021 A.U.  ± 0.010; n = 6/12 cells; 3/7 slices; 5 animals). We 
compared the prevalence of astrocytes responding to ATPA (6 in 12), with the prevalence 
of astrocytes that did not respond (6/12). Fisher’s exact test yields a p value that 
approaches, but does not reach significance (p = .053). The average fluorescence area in 
responding 0.796 A.U ± 0.27 AU, in kainite-treated rats (Kainate-group, n = 12 cells; 7 
slices, 6 animals) (Figure 4.4D, p = 0.0695).  The calcium response to application of ATP 
in astrocytes imaged in brain slices obtained from kainate rats (1.06 ± .491 AU; n = 7 
cells, 4 slices, 4 animals) were not statistically different from those imaged in slices 
obtained from control rats (1.38 ± 0.54 (control)) (Figure 4.5d, p =0.4337). As expected, 
no response to application of ACSF (n  = 10 cells; 5 slices; 4 animals) was observed in 
astrocytes imaged in slices obtained from kainate tissue (Figure 4.5d, p = 0.6188). 
Together, these data suggest that KARs are functional in a subset of astrocytes. Studies to 
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expand and clarify these results are currently ongoing. 
 
Discussion 
The main findings in this study are that reactive astrocytes in the hippocampus of 
KA-treated rats display reduced frequency and increased duration of spontaneous Ca2+ 
transients, independent of neuronal action-potential activity. Our previous finding that 
reactive astrocytes in the hippocampus increase expression of all KAR subunits 1 week 
after SE (Vargas et al., 2013) led us to hypothesize that newly expressed KARs on 
astrocytes would be functional. Focal application of the Gluk1-specific KAR agonist 
ATPA to reactive astrocytes revealed what appeared to be two distinct populations of 
reactive astrocytes, those that responded to ATPA, and those that did not. These 
preliminary findings indicate that increased protein expression of KARs results in the 
expression of functional receptors on a subset of reactive astrocytes. 
Although it is known that astrocytes typically undergo reactive gliosis following 
KA-induced SE, whether specific astrocyte targets/molecular pathways contribute to the 
progression of the epilepsy remains largely unknown. In order to better characterize 
astrocyte-specific changes during the latent period, we employed a GECI adapted for 
studying astrocytic calcium activity, Lck-GCaMP6f. We used IUE to stably transfect 
cells in the developing rat hippocampus. IUE has many advantages over viral injections, 
in that it requires less invasive means of delivery and confers longer time periods of 
expression. However, relatively inefficient transfection rates and sparse labeling, 
combined with several experimental steps with high rates of animal attrition, made this 
study time- and labor-intensive (Table 4.2). In order to circumvent these challenges in the 
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future, transgenic mice could be used. Recently, in collaboration with John White and 
Mario Capecchi’s laboratories, our group developed a new mouse line for expressing the 
GECI, GCaMP5 in specific cell populations in the brain (Gee et al., 2014). By crossing 
the GCaMP5G-IRES-tdTomato reporter mouse line, with the tamoxifen-inducible GFAP-
CreER line, GCaMP5 expression can be achieved specifically in astrocytes (Chow, 
Zhang, & Baker, 2008). Anthony Umpierre in the Wilcox laboratory recently developed a 
model of KA-induced TLE in C57BL/6J mice using repeated low-dose injections of KA, 
which can be applied to genetically-tractable mouse lines such as the Cre-inducible 
GCaMP5 reporter mouse (Gee et al., 2014; Umpierre et al., 2016). The mouse TLE 
model presents some limitations, including high rates of animal loss resulting from SE 
and infrequent spontaneous seizures, but offers the opportunity to significantly expedite 
the experimental process described here, by eliminating the need for IUE. To this end, 
there are currently ongoing experiments in our laboratory using the low-dose KA mouse 
model in GCaMP5 reporter mice to investigate if application of ATPA onto KAR’s are 
functional in reactive astrocytes following SE during the latent period. 
In this report, we described changes in spontaneous Ca2+ dynamics in reactive 
astrocytes. One group previously reported changes in astrocytic calcium activity 
following induction of SE with the chemoconvulsant agent, pilocarpine (Ding et al., 
2007). However there were several technical drawbacks to this study. They did not 
monitor vEEG during the induction of SE or the latent period, potentially missing 
important relevant data about TLE disease progression, including spontaneous seizures. 
Furthermore, they used a bulk loaded synthetic dye, Fluo4, which does not diffuse 
throughout the entire cytosolic compartment of astrocytes. In contrast, we induced SE in 
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rats while monitoring with video EEG to ensure induction of SE and to confirm that no 
spontaneous seizures had occurred, and thus, that we were studying astrocytes during 
latent period of TLE disease progression. We subsequently recorded astrocyte calcium 
dynamics in acute brain slices using Lck-GCaMP6f, a GECI that has been adapted for 
imaging of astrocyte calcium dynamics. Therefore, we were able to observe calcium 
dynamics throughout the whole cytosolic compartment, including the fine processes. 
We observed clear differences in the distribution of spontaneous event duration 
and interevent intervals in astrocytes between KA- and saline-treated groups. The 
Komolgrov-Smirnoff test detected significant differences (p < .05) in all distributions 
measured. However, this statistical test is highly powered, owing to the large number of 
ROI’s and events included in the distribution analysis, and was thus very sensitive to 
small changes in distribution. Therefore, in order to identify biologically meaningful 
differences between the two groups, we chose to focus on the distributions that showed 
clear separation in their traces. We observed that the interevent interval time was 
decreased, while event durations were longer, in reactive astrocytes from KA-treated rats, 
as compared to astrocytes from saline-treated rats. 
Astrocytes demonstrate spontaneous calcium oscillations in response to neuronal 
activity, as well as intrinsic Ca2+ excitability, or spontaneous increases in Ca2+ that are not 
triggered by neuronal activity (Nett et al., 2002; Parri, Gould, & Crunelli, 2001). We 
recorded astrocyte activity in acute brain slices in extracellular solution that included 1 
μM TTX to block action potential–dependent release of neurotransmitter. This protocol is 
in contrast to Ding et al. (2007), in which astrocyte calcium activity was measured in 
vivo without TTX. Inclusion of TTX in our experiment allowed us to focus on changes in 
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intrinsic spontaneous astrocyte calcium activity. 
Spontaneous astrocyte calcium transients are likely due to a range of factors, 
including changes in extracellular signaling molecules, expression of channels or 
transporters, regulation of receptor subunit expression, and widespread changes in 
signaling pathways influenced by inflammatory cytokines- all factors that are known 
altered during epilepsy. Following SE, and in addition to reactive astrogliosis, widespread 
changes occur in hippocampal circuitry occur, including massive cell death throughout 
the hippocampus (Thom, 2014). Even in the presence of TTX, changes in extracellular 
glutamate can occur through action potential independent neuronal neurotransmitter 
release. Thus, the increase in interevent interval of spontaneous Ca2+ events observed 
could reflect reduced number of neurons in the hippocampal circuit. Furthermore, a 
recent study in our laboratory, performed in collaboration with researchers at the 
University of Pittsburgh, used electron microscopy (EM) to investigate changes in 
astrocyte enwrapping at CA1 synapses in the hippocampus during the latent period of the 
low-dose KA model. Our results show dramatic increases in the enwrapping of synapses 
by astrocytes at the presynaptic terminals and spines and an increase in the number of 
docked vesicles at presynaptic terminals during the latent period (Rubio et al. in 
preparation). This work may suggest that the differences in spontaneous activity observed 
here could reflect changes in the astrocyte ensheathment of synapses following SE. 
Some intrinsic astrocytic oscillations (measured in the presence of TTX) appear to 
be IP3 dependent (Zur Nieden & Deitmer, 2006). Previous studies have suggested that 
mGluR5 is not expressed by adult astrocytes (Sun et al., 2013). Interestingly, it has been 
shown that the protein expression levels of mGluRs were increased in reactive astrocytes 
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in animal models of epilepsy as well as resected TLE tissue from patients, suggesting that 
increased duration of spontaneous calcium events in reactive astrocyte could be explained 
by increased signaling through the mGluR pathway (Aronica et al., 2000; Ferraguti et al., 
2001; Ulas et al., 2000; Umpierre et al., 2016). Future experiments examining intrinsic 
calcium signaling in reactive astrocytes could focus on the specific contributions of 
mGluR receptors in alterations in spontaneous astrocytic activity by examining changes 
in spontaneous event duration, or frequency (IEI) in the presence of mGluR antagonist. 
Although it is well known that astrocytes sense the neurotransmitters in 
extracellular space, and have intrinsic changes in spontaneous activity in the absence of 
synaptic transmission, we know very little about the downstream consequences of 
astrocytic calcium signaling. Experiments done on astrocytes in culture have shown that 
astrocytic Ca2+ signaling is associated with release of gliotransmitters. Several of the 
best-studied gliotransmitters include ATP, D-serine, TNF-alpha, and arachidonic acid 
metabolites. Thus, by sensing changes in intracellular Ca2+, astrocytes may actively 
participate in the information processing in the normal brain. Changes in duration and 
frequency of spontaneous event activity observed in reactive and healthy astrocytes in 
this study indicates that intrinsic spontaneous astrocyte calcium signals are changed 
during the epileptogenic process and that these changes may have important 
consequences on the development of hyperexcitability of neural networks. Further 
experimentation is needed to identify the consequences of the changes in frequency and 
duration of spontaneous events in reactive astrocytes found here. 
Previously, KARs were found to be expressed on reactive astrocytes following SE 
using both immunohistochemistry and Western Blotting on enriched glial hippocampal 
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membrane fractions 7 days following SE, leading us to hypothesize that KARs would be 
functional. Our data showed that a population of astrocytes responded to ATPA 
application with stimulus linked calcium transients, suggesting the presence of functional 
KARs in brain slices obtained from animals experiencing SE. This observation opens the 
door to a number of interesting lines of investigation that may have important 
consequences for our understanding of epileptogenesis.  
Studies are currently ongoing in our laboratory to investigate the response of 
reactive astrocytes to ATPA application in the low-dose KA-induced model of SE in 
mice. We are confident that switching to this preparation will significantly increase the 
power of our study and our ability to carefully discern the function of KARs in reactive 
astrocytes. If KARs on astrocytes in the KA mouse model are functional, we also plan to 
investigate if activation of KARs in astrocytes can be triggered by endogenously released 
glutamate, evoked via stimulation of the Schaeffer collateral pathway. Additional 
pharmacological experiments are also needed to confirm that the response of astrocytes to 
ATPA is indeed specific. This can be accomplished by repeating puffing experiments 
while perfusing of the pharmacological blocker of KARs, CNQX, in the extracellular 
bath. Furthermore, to investigate if KARs are functioning as metabotropic or ionotropic 
receptors, application of pertussis toxin to block GPCR activity or an extracellular 
solution with low Ca2+ concentration will be helpful in determining the mode of KAR 
signaling. Finally, an intriguing possibility raised by the data in these experiments 
suggest that changes in intrinsic calcium signaling during the latent period may be 
influenced by expression of KARs on reactive astrocytes. An interesting experiment 
would be to compare spontaneous astrocyte activity in control and reactive astrocytes in 
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the presence of CNQX, a KAR blocker, and TTX. 
In conclusion, this work provides the foundation for future studies needed to 
understand the changes in calcium signaling of reactive astrocytes in TLE. Utilizing 
transgenic mice expressing GCaMP5 in astrocytes will help expedite the experimental 
process. Experiments to test if focal application of 500 μM ATPA activates KARs on 
reactive astrocytes in KA-treated mice are currently ongoing. Future studies in this area 
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Table 4.1. Imaging parameters 
Parameter Value 
Image size 512 x 512 
Excitation wavelength 950 nm 
Resolution 1.25 pixels/um 
Dwell time .4 us 
Frame rate .7-.9 Hz 
Objective 20x 





Table 4.2. Experimental parameters for spontaneous analysis 
Group Animal # Slice # Cells ROI# Event# ROIs/cell 
Saline 6 12 15 717 4476 48 ± 7 





Table 4.3. Animal Numbers 










5.1 1 KA 11  Y Spontaneous 
5.2 1 KA 7  Y Spontaneous, 
ATPA, 
ACSF, ATP 
5.3 1 KA 6  N-thalamus  
5.4 1 KA 13 1 (stage 4) Undetermined  
5.5 1 KA 10  Y ATPA, 
ACSF, ATP 
5.6 1 Saline 8  Y Spontaneous 




6.1 2 Saline 11  N  
6.2 2 KA 12 3 stage (4/5) Undetermined  
6.3 2 KA 6  Y Spontaneous, 
ATPA, 
ACSF, ATP 
6.4 2 KA 7  N  
6.5 2 KA 8  N  
6.7 2 Saline 9  Y Spontaneous 
8.1 3 Saline 6  Y ATPA, 
ACSF, ATP 
8.2 3 Saline 7  N  
8.3 3 Saline 9  Y ACSF, ATP, 
ATPA 
8.4 3 KA 9  N- cortex  
8.5 3 KA 10  Y Removed 
due to z drift 
8.6 3 KA 12  Y Spontaneous, 
ATPA, 
ACSF, ATP 
9.1 4 Saline 12  Y Spontaneous, 
ATPA, 
ACSF, ATP 
9.2 4 KA 7  Y Spontaneous, 
ATPA 
9.3 4 KA 8  N  
9.4 4 KA 8  Y ATPA 
9.5 4 Saline 9  Y Spontaneous 
9.6 4 Saline 9  Y Spontaneous 





Figure 4.1. In utero electroporation procedure.
To facilitate transfection of DNA into hippocampal progenitor cells, DNA is injected 
through a glass pipette into the lateral ventricles of embryonic day (E) 14.5 brains and an 
electrical field is applied across the uterine walls. Embryos are returned to the mother and 
the dam is allow to give birth. Animals are raised until weaning.
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Figure 4.2. Timeline of study and verification of the induction of SE.  
(a) A timeline of the study showing procedures and sacrifice. (b) Saline injections did not 
result in notable changes in power over the course of recording. (c) Multiple KA 
injections were followed by an increase in power in the 0-25 Hz range, consistent with 
the occurrence of multiple stage 4/5 seizures in this animal, with a representative trace of 
a stage 5 seizure (inset). The lines at 60 Hz reflects noise at this bandwidth in both 
recordings. 
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Figure 4.3. TdTomato expression in astrocytes from saline-treated and kainate-
treated tissue. 
Maximum projections of tdTomato expression in reactive and nonreactive astrocytes in 
the stratum radiatum of CA1 in the hippocampus approximately 1 week after SE. 
TdTomato expression throughout the cytoplasm reveals a large, thick processes 
extending from the soma of reactive astrocytes and a higher density of fine spongiform 
processes in reactive astrocytes comparable to those of nonreactive astrocytes. Yellow 
arrows indicate thick processes extending from reactive astrocytes, but not in nonreactive 






































Figure 4.4. Comparison of spontaneous calcium transients in control and reactive 
astrocytes.   
(a)	 Frames from a movie demonstrating spontaneous calcium transients throughout a 
reactive astrocyte from a kainate treated rat, including activity in distinct microdomains, 
as indicated by including activity in distinct microdomains, as indicated by circles Scale 
bar = 10 μM. (b) Cumulative histograms displaying spontaneous event Interevent 
Interval, Event Duration, and Amplitude are shown, astrocytes from brain slices prepared 
from kainate-treated rats are shown in red and saline-treated rats are in black. The 
calculated p-value from a Kolmogorov-Smirnov test is shown in the plot.  
7 s 14 s 21 s 28 s
35 s 42 s 49 s 56 s
a
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Figure 4.5 Reactive astrocytes respond to ATPA. 
(a) An example astrocyte in the CA1 stratum radiatum from a control brain slice (black 
trace) does not respond to 500 μM ATPA. Half of astrocytes from brain slices from KA-
treated rats respond to ATPA (red trace), while the other half exhibited no change in 
fluorescence. The responses of individual cells with mean and SEM are shown on the far 
right. (b) As a positive control, 500 μM ATP was applied to astrocytes from control 
(black trace) and kainite-treated rats (red trace), resulting in a change in fluorescence 
area. (c) Application of extracellular solution (ACSF) demonstrated no response in either 
condition. (d) Quantification of the average change in fluorescence area in response to 
































































































































































Summary of Conclusions 
Temporal lobe epilepsy (TLE) is a devastating seizure disorder that is commonly 
refractory to antiseizure drugs (ASDs), and is also associated with a number of serious 
comorbidities. Tremendous efforts from the epilepsy research community have generated 
a wealth of knowledge about many of the changes that occur in neurons during the 
development of TLE. There are currently over 25 ASD’s that physicians can prescribe to 
treat the seizures that occur in epilepsy and in the last three decades, many new drugs 
have come to the market and have marked improvements in side-effect profile and 
tolerability. Despite this progress, the number of patients with TLE that have inadequate 
control of their seizures has remained around 30% (Serrano & Kanner, 2015). 
Furthermore, there is currently no way to prevent the development of epilepsy in patients 
at risk. Perhaps a new approach in our understanding of epilepsy is needed. 
Historically, epilepsy research has focused on neuronal subtypes and the 
dysfunction of neurons in epilepsy. Given that seizures arise from hyperexcitable 
neuronal circuits, this focus has made sense. However, there is an increasing emphasis on 
the role of astrocytes in brain circuit function, based on demonstrations that astrocytes 
play critical roles in determining the balance between neuroprotection and neurotoxicity. 
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In particular, the growing appreciation of the role of astrocytes in synapse function has 
led to the term the “tripartite synapse” (Araque, Parpura, Sanzgiri, & Haydon, 1999) 
which was coined to reflect the role of astrocytes as critical partners at the synapse. 
Changes at the tripartite synapse have been implicated in epilepsy pathophysiology, but 
relatively little is understood about functional role of astrocytes in epilepsy. 
During TLE, astrocytes become reactive and undergo widespread changes in 
morphology and protein expression throughout the hippocampus, the main brain region 
involved in seizure generation. The rat kainic acid model of status epilepticus-induced 
epilepsy is a well-described model of TLE that recapitulates a number of features seen in 
patients, including reactive astrocytes and a clinical manifestation that involves an 
initiating injury, followed by a latent period, then the appearance of spontaneous seizures. 
The goal of this dissertation was to investigate how changes in astrocytes may affect 
tripartite synapse function during the development of TLE. While Chapter 1 serves as an 
introduction and review of the role of astrocytes in epilepsy, Chapter 2 describes the 
development, construction, and validation of the novel tool, NASTIE, to genetically 
differentiate and label astrocytes and neurons during calcium imaging experiments. We 
characterized expression of the tool in a variety of preparations, including cell culture, 
acute brain slice, and examined expression patterns of the reporter fluorescent proteins 
throughout development in the rat hippocampus. These findings highlight the usefulness 
of this tool in labeling astrocytes and neurons and demonstrate its versatility for 
investigating genetically distinct cell types. In Chapter 3, we used this tool alongside 2-
photon imaging in acute brain slices to investigate changes in calcium signaling in 
reactive astrocytes during the latent period in the rat kainate model of TLE. We found 
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that reactive astrocytes have reduced frequency of spontaneous events and increased 
duration. Additional experiments in Chapter 3 tested the hypothesis that increased protein 
expression of kainate receptors (KARs) observed in reactive astrocytes during the latent 
period resulted in functional KARs. The results from the imaging experiments suggest 
that a subset of reactive astrocytes do express functional KARs, and that this pathway 
may mediate a form of pathological neuron-astrocyte signaling during epileptogenesis.   
 
Implications, Limitations, and Future Directions  
Features of the in utero electroporation technique 
In utero electroporation (IUE) was a technical approach used throughout this 
dissertation. Key features of IUE make this technique particularly useful for studying 
neurons and astrocytes in the context of epilepsy. 1) Compared to viral vectors, IUE 
targeting of the hippocampus avoids invasive injections that can cause reactive 
astrogliosis and present potentially confounding effects on astrocytes during the study of 
epileptogenic networks. 2) IUE with piggyBac plasmids overcome the loss of 
conventional episomal plasmids in IUE and the large carrying capacity makes it possible 
to deliver several transgenes to the genome (Yusa, Rad, Takeda, & Bradley, 2009). 
Furthermore, as demonstrated in Chapter 2, the use of hyperactive piggyBac transposase 
significantly increases the efficiency of piggyback-mediated integration (Yusa, Zhou, Li, 
Bradley, & Craig, 2011). NASTIE, the novel plasmid developed during this dissertation, 
contains multiple genes and is larger than 12,000 base pairs, making it too large to deliver 
with most adenoviral vectors used in gene delivery in the central nervous system (CNS). 
3) Transfection of hippocampal precursor cells results in stable transgene expression in 
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the neural lineage of radial glia, so that both neurons and astrocytes are labeled in the 
adult animal, thus enabling the study of both cell types (Chen & LoTurco, 2012). 4) 
Finally, the plasmid system used in IUE is inherently flexible. New genetic tools can be 
employed in vivo as soon as they are available without the need for the relatively long 
wait time associated with transgenic mouse lines.  
Limitations of the IUE approach also presented some challenges to the 
experiments in this dissertation. Many factors, including the site of injection, time of 
injection, and orientation of paddles, can influence the eventual expression pattern of 
transfected cells in the adult brain following IUE. Thus, it can be difficult to replicate 
expression patterns between animals and between litters, leading to substantial variation 
in the ratio of neurons to astrocytes, and the density of cells that are labeled between 
individual animals and between litters. In some contexts, the sparse labeling of IUE is a 
benefit, as it allows for the unambiguous analysis of the entire extent of a single astrocyte 
or neuron to be viewed, without overlap from the processes of neighboring cells. In 
transgenic animals, dense labeling can pose a problem and some groups have taken to 
titrating the doses of tamoxifen in order to balance expression levels with the ability to 
view individual cells (Agarwal et al., 2017). However, with IUE, sparse labeling made 
finding labeled neurons and astrocytes that were closely situated a challenge in 
investigating neuronal-glial interactions. Inconsistencies in the IUE approach also added 
significantly to the workload and difficulty of experiments in Chapter 4. Preparing 
animals for imaging and pharmacological application experiments required months of 
groundwork, and if the IUE targeting to the hippocampus was not successful, then 
months of work were lost. 
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To avoid these pitfalls, we are currently following up on the observation that 
KARs are functionally expressed in a subset of reactive astrocytes by repeating drug 
application experiments in the transgenic GCaMP5 mouse line that has been crossed with 
a GFAP-Cre line (Gee et al., 2014). Expression of GCaMP5 in this mouse line is easily 
induced by interperitoneal injections of tamoxifen and results in GCaMP5 expression in 
the vast majority of astrocytes in the brain. This approach has already significantly 
expedited data collection in reactive astrocytes. We anticipate that future experiments 
designed to dissect the mode of kainate receptor signaling in reactive astrocytes will 
benefit from this approach. 
 
Using NASTIE to investigate neuron-glial interactions 
Chapter 2 described the construction, validation, and characterization of a novel 
genetic tool to label astrocytes and neurons during Ca2+ imaging experiments. This tool 
was designed to facilitate Ca2+ imaging simultaneously in astrocytes and neurons, in 
order to investigate the interactions between these cell types at the tripartite synapse. We 
were never able to demonstrate this capability for a few reasons, which I will discuss 
here. First, astrocytes display a remarkably complex meshwork of processes, which 
penetrate the neuropil in three dimensions and can sometimes enwrap synapses. Electron 
microscopy (EM) studies indicate that astrocyte processes can be as thin as 30–50 
nanometers (Rusakov, 2015). This is beyond the optical defraction of the conventional 2-
photon microscopy approaches used in this dissertation and currently, EM is the only 
traditional imaging tool capable of resolving cellular architecture on this scale. 
It is also clear that astrocytes behave very differently from neurons at the tripartite 
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synapse. Not only do astrocytes cover much different spatial territory, their activation and 
output responses (measured by Ca2+transient via GCaMP6f) occur on temporal and 
spatial scales distinct from those of neurons (Araque et al., 2014). These fundamentally 
different characteristics have led some to hypothesize that astrocytes may act as 
integrators of circuit activity, and that they contribute to information processing by 
linking activities of neurons that occur on different spatial and temporal dimensions to 
achieve higher order integration across brain circuits. In a recent review article written by 
a number of prominent glial biologists in the field, it is proposed that astrocytes may be 
capable of enriching neuronal activity by incorporating information coming from outside 
the synaptic world (i.e., from vascular, immune and other cells) to fine tune the synaptic 
circuitry according to the environmental state (Araque et al., 2014). In light of this, 
NASTIE may be beneficial in imaging studies of neuronal-glial interactions but may need 
to be implemented alongside other techniques, and over longer imaging sessions than 




In Chapter 2, we discuss the unexpected observation that NASTIE detected a 
population of astrocytes that likely expressed Synapsin I during their lineage, resulting in 
Cre-mediated recombination of tdTomato. By P35, this population accounted for ~25% 
of all transfected GFAP-expressing cells and led us to ask whether this population of 
Cerulean-positive astrocytes reflect a functionally unique subpopulation of astrocytes. 
For now, the answer to this question remains elusive. We demonstrated subtle differences 
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in spontaneous Ca2+ activity between tdTomato-positive and Cerulean-positive 
astrocytes, and further studies are clearly needed to explore these two astrocyte groups in 
more detail.  
Over 100 years ago, Ramon y Cajal initially described extensive morphological 
heterogeneity of astrocyte populations in the brain (Garcia-Marin, Garcia-Lopez, & 
Freire, 2007). Protoplasmic astrocytes found in grey matter, fibrous astrocytes in white 
matter, Bergmann glia in the cerebellum, and Müller cells of the retina display very 
different morphologies and expression of astrocyte-enriched proteins such as GFAP (Ben 
Haim & Rowitch, 2017). More recently, there is a growing appreciation of the different 
functional characteristics of astrocyte populations throughout different brain regions. For 
example, cortical astrocytes have been shown to express NMDA receptors, while those in 
the hippocampus do not appear to express these receptor gated ion channels (Matyash & 
Kettenmann, 2010). While many researchers have suspected that additional layers of 
cellular heterogeneity exist among astrocytes within the same circuits and brain regions, 
only recently have the genetic and imaging tools been available to investigate this. Two 
studies in the past year have revealed very interesting and unexpected aspects of astrocyte 
heterogeneity. One recent paper elegantly demonstrated that the release of sonic 
hedgehog (SHH) by neurons acts as a critical signaling factor to determine the 
transcriptional profiles of nearby mature astrocytes. Furthermore, they found that 
astrocytes in different brain regions responded to SHH differently. Cerebellar Bergmann 
glia responded to SHH by increasing expression of glutamate receptors, while 
protoplasmic astrocytes from the hippocampus respond to SHH with changes in 
expression of the potassium channel Kir4.1, which altered their potassium buffering 
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capabilities(Farmer et al., 2016). Another recent study used a form of fluorescent 
activated cell sorting  (FACS) to identify 5 unique populations of astrocytes in the brain, 
each with its own unique molecular profile and functions related to development and 
synaptogenesis (John Lin et al., 2017). Based on these two high profile studies, astrocyte 
heterogeneity appears to be having its moment in the spotlight, and a tool like NASTIE, 
which not only labels genetically distinct populations, but also can deliver optogenetic 
tools to study function, may prove useful going forward. 
To investigate if Cerulean-positive astrocytes might represent a functionally 
unique genetic subtype, we investigated one aspect of astrocyte physiology-spontaneous 
Ca2+ activity. However, many other important functional properties of these astrocytes 
remain unexplored; therefore, further work is needed to investigate the origin and 
characteristics of Cerulean-positive and tdTomato-positive astrocytes. I am particularly 
intrigued about the origin of Cerulean-positive astrocytes. Because Cre-recombination 
acts as a lineage tracer, it is impossible to determine, based on expression of the Cerulean 
fluorophore alone, whether Cerulean-positive cells constitutively express Synapsin I, 
expressed Synapsin I transiently at some point in their past, or are derived from a cell that 
expressed Synapsin I at some point. One possibility for future experiments is to do FACS 
sorting of tdTomato-positive and Cerulean-positive astrocytes, followed by gene 
expression profiling to look closely at the cellular differences between these two groups. 
However, one potential pitfall of this experiment is that if IUE yields sparse labeling, 
there may not be sufficient cell numbers after FACS sorting. As an alternative, single cell 
RNA sequencing could be done on individual tdTomato-positive/Cerulean-positive 
astrocytes that are isolated in brain slices. This could be a potentially efficient method to 
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determine where Cerulean-positive and tdTomato-positive exhibit distinct molecular 
profiles.  
 
How should changes in astrocyte Ca2+ activity be interpreted? 
Over the past two decades, much emphasis has been placed on recording Ca2+ 
signals within astrocytes as a basis to understand their roles in neural circuits. Difficulties 
in detecting and interpreting astrocyte Ca2+ signals have led to much debate and 
controversy within the field (Bazargani & Attwell, 2016). The focus on Ca2+ is based on 
the fact that Ca2+ is a ubiquitous second messenger and intracellular Ca2+ signals are 
thought to be the primary signal by which astrocytes interact with neurons and blood 
vessels. Astrocyte Ca2+ transients are widely considered to be a form of cellular 
excitability; however, these transients are extremely diverse and do not exhibit 
stereotyped electrical activity like action potentials. Therefore, it is likely that the 
functional consequences of astrocyte Ca2+ are much more diverse and complex than 
neuronal action potentials (Nimmerjahn & Bergles, 2015). GECIs optimized for 
astrocytes, such as Lck-GCaMP6, have made detecting calcium transients in astrocyte 
processes relatively simple. However, because only a small region of the astrocyte, and 
thus only a fraction of microdomains, are visible in a given cell and can be measured 
within the focal plane of a 2-photon microscope, it is difficult to fully appreciate their 
complete spatiotemporal profiles (particularly in the z-direction). Furthermore, fine 
astrocyte processes can be extremely small and therefore undetectable by conventional 2-
photon microscopy. We were able to detect Ca2+ transients in very small processes 
throughout astrocytes. However, it is possible that even with the newest, most sensitive 
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and brightest, GCaMP6f, we are missing potentially nanoscopic subtle Ca2+ events. 
Indeed, physiological Ca2+ activity in astrocytes may extend beyond what can be detected 
with currently available Ca2+ indicators (Zheng et al., 2015). Therefore, there may be 
very subtle physiological changes that link particular types of Ca2+ signals and their 
downstream consequences. 
Interpreting the downstream consequences of Ca2+ activity in astrocytes is 
difficult. It is known that intracellular Ca2+ can activate many transcription factors and 
downstream enzymes including PKC, MEF-2, NFAT, NF-kB, CaMKII and CREB, so 
Ca2+ activity invariably plays a role in gene expression (Mellstrom, Savignac, Gomez-
Villafuertes, & Naranjo, 2008). Within the glia field, there has also been a significant 
controversy in the field as to the role of these Ca2+ signals in the release of signaling 
molecules, called gliotransmitters from astrocytes (Hamilton & Attwell, 2010). While it 
now seems clear that astrocytes do indeed release signaling molecules such as ATP and 
D-serine (Dallerac, Chever, & Rouach, 2013), whether this happens in a Ca2+-dependent 
manner in processes is still unsettled (Hamilton & Attwell, 2010). 
A recent study convincingly showed that one function of Ca2+ signaling in 
astrocyte microdomains is to provide metabolic support, by sensing increasing energy 
demands and activating oxidative phosphorylation in mitochondria (Agarwal et al., 
2017). Using GCaMP3 expressing mice, they demonstrated that neuronally evoked 
astrocyte Ca2+ transients initiated in the astrocyte processes propagate into mitochondria-
rich somatic regions, which stimulate oxidative phosphorylation. Then, ATP produced by 
mitochondria in the soma in turn diffuse back into the perisynaptic processes and 
supplements ATP produced by local glycolysis during periods of intense glutamate 
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uptake.   
 
Role of KARs in epileptogenesis 
We demonstrated that KARs expressed on reactive astrocytes during the 
development of epilepsy are functional in a subset of cells, suggesting a new pathway 
that could represent and important functional alteration contributing to the development 
of epilepsy. Due to experimental limitations associated with IUE, discussed above, the 
statistical power of these experiments was rather low. We are currently conducting 
similar experiments in our laboratory, using transgenic mice that express GCaMP5 in 
astrocytes throughout their brain, and applying ATPA to investigate the responses of 
KARs on reactive astrocytes (Gee et al., 2014). Because in this transgenic mouse model, 
every astrocyte in the stratum radiatum expresses GCaMP5, placement of pipettes for 
agonist application is simplified. However, there are a few important caveats to keep in 
mind, as we repeat these experiments in the low-dose kainate mouse model of TLE. First, 
Western Blot and IHC needs to be performed, in order to confirm that reactive astrocytes 
express KARs during the latent period. We currently do not know if reactive astrocytes 
during the latent period in the mouse express KAR subunits, but a good indication will be 
if we see a Ca2+ response upon application of ATPA. Furthermore, unlike the rat model 
of KA-induced TLE, where the vast majority of rats treated with KA go on to develop 
epilepsy, the rate of spontaneous seizures (i.e., development of chronic epilepsy) in the 
mouse model is low (Umpierre et al., 2016). Future experiments to pharmacologically 
dissect the pathway involved in KAR activation in reactive astrocytes during 
epileptogenesis are planned. Because KARs can signal as ionotropic and metabotropic 
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receptors, it will be important to use pharmacology to parse the specific mode of 
signaling. Furthermore, we plan to investigate if KARs on reactive astrocytes can be 
activated in response to endogenous glutamate release (i.e., high frequency stimulation) 
of the Schaeffer collateral pathways.  
 
 
Closing Remarks and Outlook 
The concept of the tripartite synapse reflects a new understanding of brain 
physiology. Astrocytes have traditionally been considered a passive, homogenous cellular 
population, but accumulating evidence places them as functionally diverse, critical 
players in the brain in both health and disease. The need for innovative, new approaches 
to studying changes in circuits during the development of epilepsy are desperately needed 
in order to provide improved therapies for patients. This dissertation lays the groundwork 
for future imaging experiments at the tripartite synapse using the novel genetic tool, 
NASTIE, and points to a kainate-receptor mediated signaling pathway that may reflect an 
important functional change in reactive astrocytes during the development of epilepsy. 
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APPENDIX 
COULD ASTROCYTES BE USED TO BEAT EPILEPSY? EXPERIMENTS 
IN dnSNARE MICE DRUM UP NEW HOPE1 
Historically, epilepsy research has focused on understanding the dysfunction of 
neuronal cell types in the progression of TLE. More recently, a subset of glial cells, 
known as astrocytes, have become implicated in the process of epileptogenesis. 
Following status epilepticus (SE), astrocytes undergo a process termed reactive gliosis 
wherein these cells exhibit dramatic changes in morphology and protein expression 
(Binder & Steinhauser, 2006). These changes are a hallmark of TLE; however, the 
functional consequences of this process on disease progression remain unclear 
(Steinhauser & Boison, 2012). Reports have demonstrated that astrocytes begin to 
increase expression of a variety of receptors including metabotropic glutamate receptors 
(Aronica et al., 2000) and kainate receptors (Vargas, Takahashi, Thomson, & Wilcox, 
2013) during SE-induced epilepsy, suggesting that astrocytes may be responding to 
changes in extracellular glutamate in the synaptic cleft during seizures. Astrocytes are 
considered an integral part of the tripartite synapse and have been hypothesized to be 
capable of modulating synaptic transmission via the vesicular release of neurotransmitters 
including glutamate (Perea & Araque, 2007), though this remains a controversial topic 
 This article was published in Epilepsy Currents. Meredith Gibbons and Karen Wilcox. (2014). This 
content is freely available through Creative Commons licensing. 
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within the glial biology field (Nedergaard & Verkhratsky, 2012). This model suggests 
that astrocytes could contribute to the excitation of surrounding neurons through a direct 
mechanism, and thus may offer a new potential therapeutic target in epilepsy. 
By far, the greatest challenge faced by those studying the role of astrocytes in 
epilepsy has been a lack of astrocyte-specific tools to dissect the contribution of these 
cells to neuronal networks. Fortunately, in the last few years, the increased accessibility 
of cell-specific inducible transgenic animals and optogenetic sensors, such as the GCaMP 
family of proteins, offers hope that exciting breakthroughs lay just beyond the horizon 
(Li, Agulhon, Schmidt, Oheim, & Ropert, 2013). In this vein, a recent study by 
Clasadonte and colleagues used astrocyte-specific transgenic animals to investigate the 
role that astrocyte-mediated transmitter release may play in the progression of TLE. 
Previously this group developed a line of tamoxifen-inducible transgenic mice 
called the dominant negative SNARE (dnSNARE) mice wherein the vesicular machinery 
required for the release of transmitters is selectively disrupted in astrocytes (Pascual et 
al., 2005). In the current study, 2-month-old dnSNARE and WT male littermate mice 
were administered low-dose injections of pilocarpine and allowed to undergo status 
epilepticus (SE) for 90 minutes before terminating the SE with diazepam. After a latent 
period following SE, these animals went on to develop TLE, characterized by 
spontaneous recurrent seizures. Appropriately, this progressive development of seizures 
was tracked using long-term video EEG recording. dnSNARE animals had a longer 
latency to the development of spontaneous recurrent seizures than wildtype age-matched 
controls. Furthermore, during the chronic epilepsy period, the dnSNARE mice had less 




number of interictal spikes as compared to wildtype controls, suggesting that the loss of 
vesicular release of signaling molecules in the dnSNARE mice could modify 
epileptogenesis.  
The investigators also looked at behavioral and histological markers associated 
with TLE 8 months after SE. They assessed locomotor activity using an open field 
behavior test. Intriguingly, wildtype animals treated with pilocarpine showed less 
locomotor activity than their dnSNARE counterparts. Clasadonte et al. also quantified the 
relative number of neurons using an antibody for NeuN. Profound neuronal cell death 
was associated with SE in the hilar region of the dentate gyrus in WT animals, but not 
dnSNARE animals, suggesting that the dnSNARE mutation is neuroprotective. The 
authors also investigated reactive gliosis using immunohistochemistry for glial fibrillary 
acidic protein (GFAP, a protoplasmic astrocytic marker) and found less GFAP expression 
in the dnSNARE mice after SE, compared to controls. These studies pointed to a reduced 
pathology of brain regions that are normally quite sensitive to SE. 
They then turned to an in vitro acute brain slice model of epileptiform activity to 
investigate changes in synaptic physiology. In brain slices prepared from dnSNARE 
animals, there was a reduced latency to onset of epileptiform activity, and a decrease in 
the number of ictal events compared to WT animals. Furthermore, patch-clamp 
recordings from CA1 pyramidal neurons 5 months after pilocarpine treatment indicated 
that the NMDA currents were significantly reduced in the dnSNARE mice. Finally, 
Clasadonte and coauthors found that treatment with D-AP5, an NMDA receptor 
antagonist, during the latent period of epileptogenesis was sufficient to phenocopy the 




glutamate exerts pro-epileptogenic effects selectively on NMDA receptors. 
This investigation offered a valuable new perspective on understanding the role of 
astrocyte-derived chemical transmission on the process of epileptogenesis. A particular 
strength of the study was the use of astrocyte-specific inducible genetic techniques, as 
selectively distinguishing astrocyte vs. neuronal contributions to networks has been a 
continuous limitation in other studies attempting to understand astrocyte function in 
epileptogenesis. 
Furthermore, the use of long-term chronic EEG and behavioral monitoring was 
another considerable strength of the study and provided important relevant data on the 
various phases of TLE disease progression. One concerning aspect of the experimental 
design was the lack of electrographic monitoring during pilocarpine-induced SE for all 
animals in the study. Although behavioral seizures were assessed, this evidence alone is 
inadequate to conclude that the severity of the SE was the same in both the dnSNARE 
and their wildtype counterparts. Thus, it cannot be ruled out that the severity of SE was 
reduced in the dnSNARE animals, possibly explaining the reductions in seizures, as well 
as pathogenic and behavioral differences between the two groups. In addition, analysis of 
seizures was performed only on 4-6 individual mice. Given the variability in number of 
seizures among the different cohorts, forthcoming studies should include larger sample 
sizes when assessing behavioral and electrographic seizure measures.  
Future directions will hopefully address the selective mechanisms that control 
glutamate release from astrocytes in wildtype animals, as this still remains a contentious 
topic within the field of astrocyte physiology. In addition, caution should be taken to not 




elaboration of the NMDAR-dependent pathway in which astrocyte-selective inhibition of 
vesicle release is effective in diminishing progression of TLE is warranted. While the 
approach taken in this study suggests that glutamate released from astrocytes may be 
contributing to the progression of TLE, the authors did not rule out contributions from 
other gliotransmitters such as D-serine, a required co-agonist of the NMDA receptor. 
Most excitingly, the study by Clasadonte and colleagues provides evidence 
suggesting that astrocytes could serve as potential disease modifying targets in TLE, the 
Holy Grail for epilepsy researchers. Thus, our goal should be to conduct experiments that 
provide nuanced information about the mechanistic role of astrocytes during 
epileptogenesis. With so many new and exciting emerging technologies, obtaining robust 
data that clarifies and strengthens our models is well within reach. 
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